Method for producing cells
The use of a crosslinked vinyl alcohol polymer hydrogel in cell culture vessels allows for the stable detachment of adherent cells using liquid flow, addressing the issues of cell damage and contamination in existing methods, and enabling efficient, large-scale cell production.
Patent Information
- Application Number
- PCT/JP2024/017570
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-15
- Filing Date
- 2024-05-13
- Publication Date
- 2024-11-21
AI Technical Summary
Current methods for detaching adherent cells from culture carriers often damage cells due to the use of proteolytic enzymes and may introduce foreign substances, and existing alternatives are not suitable for large-scale industrial bioreactors or provide limited growth options.
A method using a culture vessel with a hydrogel comprising a crosslinked vinyl alcohol polymer, where cells are cultured and detached using a liquid flow with minimal proteolytic enzyme concentration, allowing for stable cell production and maintenance of cell activity.
Enables the stable detachment of cells from culture carriers without proteolytic enzymes, maintaining cell activity and suitability for industrial-scale production, while avoiding contamination and temperature-related activity decreases.
Smart Images

Figure JPOXMLDOC01-APPB-I000001 
Figure JPOXMLDOC01-APPB-T000002 
Figure JPOXMLDOC01-APPB-T000003
Abstract
Description
Cell production method
[0001] This patent application claims priority under the Paris Convention based on Japanese Patent Application No. 2023-80024 (filed May 15, 2023) and Japanese Patent Application No. 2023-80030 (filed May 15, 2023), the entire contents of which are incorporated herein by reference. The present invention relates to a method for producing cells using a hydrogel.
[0002] In the fields of regenerative medicine and cancer treatment, cell therapy is performed in which cells with specific functions are produced ex vivo and then administered to patients to restore functions lost due to disease, accidents, etc. Most of these therapeutic cells are adhesive cells that require a scaffold for survival, proliferation, and functional expression.
[0003] In conventional production of adherent cells, cells typically grow during culture and cover the surface of the cell culture carrier until they reach a confluent state. Once the cells reach a confluent state, they are detached from the surface of the cell culture carrier using a protease such as trypsin, and the detached cells are either recovered or re-attached to a new cell culture carrier for use as starting cells. However, such protease enzymes have the problem of potentially damaging the target cells. Furthermore, because protease enzymes are typically derived from animals, there is a risk that foreign substances such as viruses from the animal may be introduced into the culture system via the protease. For this reason, cell detachment methods that do not use proteases have been investigated.
[0004] For example, Patent Document 1 describes a method for harvesting cultured cells from a soluble substrate, the method comprising the steps of: separating the cultured cells from the substrate by digesting the substrate by exposing the substrate to (i) a chelating agent, (ii) an enzyme, or (iii) a chelating agent and an enzyme, wherein the separation results in a harvesting solution; and, after the separating step, performing a series of washing and / or centrifugation cycles of the components of the harvesting solution, wherein the substrate comprises a polygalacturonic acid compound selected from at least one of pectinic acid, partially esterified pectinic acid, partially amidated pectinic acid, and salts thereof, and an adhesive polymer on the surface of the polygalacturonic acid compound.
[0005] Patent Document 2 describes a thermosensitive polymer compound obtained by graft-polymerizing an N-isopropylacrylamide polymer onto gelatin, and describes that, for example, an aqueous solution of this thermosensitive polymer compound is applied to the surface of a culture dish and dried to obtain a sheet-like cell culture substrate, and cells are attached to the surface and cultured thereon, and then the temperature is adjusted to be lower than the lower critical point temperature of the thermosensitive polymer compound (usually 31°C for polyisopropylacrylamide (PNIPAM)-grafted gelatin), which makes the surface of the thermosensitive polymer compound hydrophilic, reducing cell adhesiveness and allowing cells to be detached from the cell culture substrate.
[0006] Patent Document 3 describes a method for culturing adherent cells, which comprises culturing adherent cells in a liquid medium in a culture vessel made of a polymer containing an alicyclic structure, detaching the cells from the culture vessel by a liquid flow without adding a protease, and suspending the cultured cells in the liquid medium.
[0007] Patent document 4 describes a method for culturing stem cells, which comprises growing stem cells adhered to a culture vessel containing a liquid medium in the culture vessel, detaching the grown stem cells from the culture vessel using a detachment solution that does not contain a protease but contains at least a chelating agent, and suspending the detached stem cells in a liquid medium, wherein at least the portion of the culture vessel to which the stem cells adhere is formed from a polymer containing an alicyclic structure.
[0008] JP-T-2022-536651 A JP-A-11-349643 WO 2017 / 104618 JP-A-2018-201403
[0009] However, according to the inventors' research, the method of Patent Document 1 recovers dissolved substrate components and digestion reagents along with the target cells, necessitating washing to remove these undesired substances. However, because the recovered materials are liquid, the undesired substances cannot be completely removed. The method of Patent Document 2 requires lowering the culture temperature (usually around 37°C) to the detachment temperature (31°C or lower) to detach cells from the cell culture substrate. However, if this reduction takes time, cell activity decreases during that time. In particular, in scaled-up culture vessels (e.g., large-capacity industrial bioreactors), the aforementioned temperature reduction requires long periods of time (e.g., several hours or more), making the method described in Patent Document 1 practically unsuitable for cell production in scaled-up culture vessels. Patent Documents 3 and 4 also disclose culture methods using culture vessels made of alicyclic structure-containing polymers, but because cells do not spread on alicyclic structure-containing polymers, these methods can only be used for flat-plate culture. For example, it is difficult to culture the scaffold material in an industrial bioreactor in which the scaffold material is suspended in a liquid medium, and the methods of Patent Documents 3 and 4 cannot be substantially adopted for industrial cell production.
[0010] In view of the above, the problem to be solved by the present invention is to provide a method for producing cells that can detach cells from cell culture carriers substantially without using protease or using protease only at a low concentration, and can stably produce cells that maintain their activity well.
[0011] The present inventors conducted extensive research into cell production methods in order to solve the above-mentioned problems, and have completed the present invention. Specifically, the present invention encompasses the following preferred embodiments. [1] A cell production method comprising the steps of: preparing a culture vessel containing a liquid medium, a hydrogel comprising a crosslinked vinyl alcohol-based polymer, and a composition comprising raw material cells; culturing the raw material cells on the surface of the hydrogel; and detaching the cultured cells from the surface of the hydrogel by a liquid flow. [2] A cell production method comprising the steps of: preparing a culture vessel containing a liquid medium, a hydrogel comprising a crosslinked vinyl alcohol-based polymer, and a composition comprising raw material cells; culturing the raw material cells on the surface of the hydrogel; and contacting at least a portion of the composition in the culture vessel with a solution containing a protease at a concentration of 1.5 mg / mL or less and a chelating agent at a concentration of 0.01 mg / mL or more, thereby detaching the cultured cells from the surface of the hydrogel. [3] The method described in [2], further comprising the step of detaching the cultured cells from the surface of the hydrogel by a liquid flow. [4] The method of [1] or [3], wherein the liquid flow is generated by one or more of the following means (i) to (iv): (i) suction and discharge of at least a portion of the composition through a tube installed in the culture vessel, (ii) rocking the composition, (iii) stirring the composition with a stirring blade, and (iv) discharging gas and / or liquid into the culture vessel. [5] The method of any of [1] to [4], wherein the hydrogel comprises a cell adhesion factor. [6] The method of any of [1] to [5], wherein the hydrogel is in the form of irregular particles, spherical particles, a micromolded object, an arbitrarily shaped article formed by a 3D printer, a film, a fiber, a hollow fiber, a porous monolith, a coated article, or a mixture of two or more thereof. [7] The method of [6], wherein the hydrogel in an equilibrium swollen state in a liquid medium is in the form of spherical particles having an average particle diameter of 10 to 5,000 μm. [8] The method according to any one of [1] to [7], wherein the vinyl alcohol polymer has an ethylenically unsaturated group and a viscosity-average degree of polymerization measured in accordance with JIS K 6726:1994 of 300 or more.[9] The method according to any one of [2] to [8], wherein the chelating agent is ethylenediaminetetraacetic acid or glycoletherdiaminetetraacetic acid.
[10] The method according to any one of [1] to [9], wherein the culture vessel is a bioreactor.
[11] The method according to any one of [1] to
[10] , further comprising a step of separating the detached cells from the hydrogel.
[12] The method according to
[11] , wherein the detached cells and the hydrogel are separated using a porous material.
[13] The method according to
[11] , wherein the detached cells and the hydrogel are separated by a difference in sedimentation velocity.
[14] A method for producing cells, comprising: recovering the hydrogel separated by the method according to any one of
[11] to
[13] ; preparing a culture vessel containing a composition comprising a liquid medium, the recovered hydrogel, and starting cells; and culturing the starting cells on the surface of the recovered hydrogel.
[0012] According to the present invention, a method for producing cells can be provided which enables cells to be detached from cell culture carriers substantially without using protease or using protease only at a low concentration, and enables stable production of cells with well-maintained activity.
[0013] Hereinafter, embodiments of the present invention will be described in detail. Note that the scope of the present invention is not limited to the embodiments described here, and various modifications can be made without departing from the spirit of the present invention.
[0014] The method for producing cells of the present invention includes the steps of: preparing a culture vessel containing a liquid medium, a hydrogel containing a crosslinked vinyl alcohol polymer, and a composition containing raw material cells (preparation step); culturing the raw material cells on the surface of the hydrogel (culture step); and detaching the cultured cells from the surface of the hydrogel by a liquid flow (detachment step). Hereinafter, this production method will also be referred to as the "first production method."
[0015] [Preparation Step of First Production Method] The composition contained in the culture vessel comprises a liquid medium, a hydrogel comprising a crosslinked vinyl alcohol polymer, starting cells, and optionally optional components. A composition obtained by mixing the liquid medium, hydrogel, starting cells, and optionally optional components may be introduced into the culture vessel. Alternatively, the liquid medium, hydrogel, starting cells, and optionally optional components may be introduced in any order. Alternatively, a premix obtained by premixing two or more substances selected from the group consisting of the liquid medium, hydrogel, starting cells, and optionally optional components may be introduced in any order, followed by the remaining substances. The method of mixing or introducing the composition or premix is not particularly limited, and any conventional method can be used.
[0016] The hydrogel before mixing or introduction may be in a dry state or may contain a liquid such as water, a water-soluble organic solvent, or a liquid medium (preferably the same liquid medium as the liquid medium contained in the composition). It may also be in an equilibrium swollen state in the liquid. As used herein, "dry" refers to a state in which volatile components such as water have been reduced. For example, a substance (e.g., a hydrogel) can be dried by hot air drying, aeration drying, vacuum drying, or freeze-drying until the mass of the substance reaches a constant weight. Furthermore, "equilibrium swollen state" refers to a state in which the hydrogel is swollen with the liquid until equilibrium is reached. Immersing the hydrogel in the liquid removes unreacted raw materials, including the radical polymerization initiator, non-crosslinked polymer components, and / or other residues, thereby further reducing the content of unreacted raw materials, non-crosslinked polymer components, and / or other residues, and thereby reducing the toxicity of the hydrogel to cells. To further remove unreacted raw materials, non-crosslinked polymer components, and / or other residues, the above liquid can be replaced and the immersion procedure repeated. Alternatively, the hydrogel may be dried and then immersed in the liquid again to bring it to an equilibrium swollen state before being mixed or introduced. The hydrogel can be dried, for example, by passing it through an optional drying step described below.
[0017] The preparation step is usually carried out under the same temperature and atmospheric conditions as the culture step described below.
[0018] <Hydrogel> In the culture vessel in the preparation step, the source cells are present on the surface of a hydrogel containing a crosslinked vinyl alcohol polymer. In the subsequent culture step, the source cells grow using the hydrogel as a scaffold. That is, the hydrogel functions as a cell culture carrier.
[0019] The hydrogel contains a crosslinked vinyl alcohol polymer and, optionally, an optional component other than the cell adhesion factor, and preferably contains a crosslinked vinyl alcohol polymer, a cell adhesion factor, and, optionally, the optional component.
[0020] The swelling degree of the hydrogel, as expressed by the following formula (1), is preferably 200% or more, more preferably 300% or more, and even more preferably 400% or more. When the swelling degree is equal to or greater than the lower limit, the hydrogel can swell in a liquid medium even if the dry mass of the hydrogel is relatively small, providing a sufficient scaffold. The swelling degree can be adjusted to equal to or greater than the lower limit, for example, by adjusting the amount of multifunctional crosslinker in the crosslinked vinyl alcohol polymer, adjusting the amount of ethylenically unsaturated groups, and / or adjusting the content of the vinyl alcohol polymer in the uncrosslinked polymer solution during the hydrogel preparation process. The upper limit of the swelling degree is not particularly limited and is typically 10,000% or less. The swelling degree can be calculated by measuring the dry mass of the hydrogel, immersing it in ion-exchanged water, saline, or phosphate-buffered saline for 2 hours or more, blotting the liquid on the surface of the hydrogel with a paper sheet or removing it by centrifugation, and then measuring the swollen mass of the hydrogel using the following formula (1): Swelling degree [%] = (mass of swollen hydrogel [g] / mass of dry hydrogel [g]) × 100 Formula (1)
[0021] The hydrogel is preferably in the form of amorphous particles, spherical particles, micromolded bodies, arbitrarily shaped articles molded using a 3D printer, films, threads, hollow fibers, porous monoliths, coated articles, or a mixture of two or more thereof. Spherical particles include not only perfectly spherical particles, but also ellipsoidal particles, spherical particles with missing or protruding portions, ellipsoidal particles with missing or protruding portions, spherical particles with protrusions or wrinkles on the surface, and porous spheres. A micromolded body is a molded body with fine irregularities on the surface or inside, and the size of the microfabrication when the hydrogel is in an equilibrium swelling state is typically 10 to 1000 μm. An arbitrarily shaped article molded using a 3D printer is, for example, any shape that can be molded using a stereolithography, inkjet, or nozzle extrusion 3D printer.
[0022] In one embodiment, the hydrogel in an equilibrium swollen state in a liquid medium (particularly a liquid medium contained in the composition) is preferably spherical particles having an average particle size of 10 μm or more, more preferably 20 μm or more, even more preferably 50 μm or more, even more preferably 80 μm or more, even more preferably 100 μm or more, and preferably 5,000 μm or less, more preferably 4,500 μm or less, even more preferably 4,000 μm or less, even more preferably 3,000 μm or less, even more preferably 2,000 μm or less, even more preferably 1,500 μm or less. Preferred average particle sizes are in the range of 10 to 5,000 μm, more preferably 20 to 4,500 μm, even more preferably 50 to 4,000 μm, even more preferably 80 to 3,000 μm, even more preferably 100 to 2,000 μm, and even more preferably 100 to 1,500 μm.
[0023] In one embodiment, the hydrogel in an equilibrium swollen state in phosphate buffered saline is preferably spherical particles having an average particle size of 10 μm or more, more preferably 20 μm or more, even more preferably 50 μm or more, still more preferably 80 μm or more, even more preferably 100 μm or more, and preferably 5,000 μm or less, more preferably 4,500 μm or less, even more preferably 4,000 μm or less, still more preferably 3,000 μm or less, still more preferably 2,000 μm or less, and still more preferably 1,500 μm or less. The average particle size is preferably in the range of 10 to 5,000 μm, more preferably 20 to 4,500 μm, even more preferably 50 to 4,000 μm, still more preferably 80 to 3,000 μm, still more preferably 100 to 2,000 μm, and still more preferably 100 to 1,500 μm.
[0024] The average particle size of the hydrogel can be measured using a laser diffraction / scattering particle size distribution analyzer, as described in the Examples below. The average particle size in the present invention refers to the volume-based average particle size (sphere-equivalent diameter) of particles in an equilibrium swollen state. Therefore, even when measuring using a microscope, the average particle size can be measured by observing the particles after swelling, as described in the Examples below. Furthermore, when the hydrogel is swollen in a liquid other than phosphate-buffered saline (e.g., a liquid medium), the average particle size of the hydrogel in an equilibrium swollen state in phosphate-buffered saline can also be measured by washing and drying the hydrogel using a conventional method and then bringing the hydrogel to an equilibrium swollen state in phosphate-buffered saline. An average particle size that is equal to or greater than the lower limit and equal to or less than the upper limit, or within the above range, is preferable because it provides excellent handleability and allows for easy and rapid separation of the detached cells from the hydrogel in the separation step described below. Easy and rapid separation not only improves cell production efficiency but also better maintains the activity of the produced cells, thereby achieving more stable cell production. This advantage is also useful when the culture vessel is a large-capacity bioreactor. The average particle size can be adjusted to be equal to or greater than the lower limit and equal to or less than the upper limit, or within the above range, for example, by employing an appropriate molding method in the process of preparing the hydrogel and / or selecting a classification method after molding.
[0025] Other than spherical particles, the hydrogel is also preferably in the form of a film, thread or coated article.
[0026] In one embodiment in which the hydrogel is in the form of a film, for example, when the film hydrogel is used in a fluidized-bed bioreactor or stirred-bed bioreactor, as described below, the film hydrogel needs to be dispersed in the composition. Therefore, the thickness, width, and length of the film hydrogel brought to an equilibrium swollen state in a liquid medium (particularly the liquid medium contained in the composition) are preferably 10 to 5,000 μm, more preferably 30 to 2,000 μm, and even more preferably 50 to 1,000 μm. On the other hand, when the film hydrogel is used in a fixed-bed bioreactor, as described below, this does not apply; a larger film hydrogel may be used, for example, in the form of a spiral membrane. In this case, from the viewpoint of maintaining the mechanical strength of the film hydrogel, the thickness of the film hydrogel is preferably 10 to 5,000 μm, more preferably 30 to 2,000 μm, and even more preferably 50 to 1,000 μm; the width is preferably 10 to 5,000 mm, more preferably 100 to 3,000 mm, and even more preferably 300 to 2,000 mm; and the length is preferably 0.5 to 100 m, more preferably 1 to 50 m, and even more preferably 2 to 30 m. The thickness, width, and length are the dimensions of the film hydrogel brought to an equilibrium swollen state in a liquid medium (particularly the liquid medium contained in the composition). The thickness, width, and length of the film hydrogel can be measured by observing the film hydrogel with a microscope or the like.
[0027] In one embodiment in which the hydrogel is in the form of threads, for example, when the thread-shaped hydrogel is used in a fluidized-bed bioreactor or a stirred-bed bioreactor, as described below, the thread-shaped hydrogel needs to be dispersed in the composition. Therefore, the diameter and length of the thread-shaped hydrogel brought to an equilibrium swollen state in a liquid medium (particularly a liquid medium contained in the composition) are preferably 10 to 5,000 μm, more preferably 30 to 2,000 μm, and even more preferably 50 to 1,000 μm, respectively. The diameter and length of the thread-shaped hydrogel can be measured by observing the thread-shaped hydrogel under a microscope or the like.
[0028] The term "coated article" refers to a substrate (e.g., the aforementioned amorphous particles, spherical particles, micromolded bodies, arbitrarily shaped articles formed by 3D printing, films, trays, threads, hollow fibers, porous monoliths, plates typically used as culture vessels, well plates, flasks (including T-flasks, shaker flasks, spinner flasks, etc.), chamber slides, dishes, tubes, bottles, roller bottles, and bags (including shaker bags)) coated with a hydrogel. The substrate material can be freely selected from one or a combination of two or more materials, such as glass, polyolefin, polymethyl methacrylate, polystyrene, polyester, polyolefin, ethylene-vinyl alcohol copolymer, polyamide, and polyimide. To prevent peeling of the coated hydrogel from the substrate when it swells in a liquid medium (particularly the liquid medium contained in the composition), the thickness of the hydrogel layer in the coated article, which has been brought to an equilibrium swollen state in a liquid medium, is preferably 0.05 to 1,000 μm, more preferably 0.1 to 700 μm, and even more preferably 0.2 to 500 μm. The thickness of the hydrogel layer can be measured by a method in which the coated article is dried, and then the cross section of the article is photographed using an electron microscope, and the thickness is then converted into the thickness in an equilibrium swollen state; a method in which a portion of the hydrogel layer is peeled off and measured using a film thickness step meter; or a method using an ellipsometer or the like.
[0029] The hydrogel is preferably sterilized from the viewpoint of use in cell production. Sterilization in the present invention does not necessarily mean sterilization under conditions of SAL=10 as required for pharmaceuticals or medical devices used on the human body. -6 It is not necessary to achieve the sterility assurance level below the sterility assurance level for research and testing purposes, and preferably SAL = 10. -3 More preferably, SAL=10 -4 More preferably, SAL=10 -5 However, when incorporated into a pharmaceutical product or medical device used on the human body, or when used in the manufacture of such an item, the SAL is 10 -6 It is preferable that:
[0030] The proportion of the hydrogel in the composition is, for example, 0.005 to 50% by mass, preferably 0.01 to 40% by mass, and more preferably 0.05 to 30% by mass, based on the total mass of the composition. The mass of the hydrogel in this case is the mass in a dry state.
[0031] <Method for Preparing Hydrogel> The method for preparing the hydrogel is not particularly limited. The hydrogel can be prepared, for example, by a method including a step of preparing an uncrosslinked polymer solution containing a vinyl alcohol-based polymer (uncrosslinked polymer solution preparation step), then a step of molding the uncrosslinked polymer solution (molding step), and then a step of crosslinking the molded vinyl alcohol-based polymer (crosslinking step).
[0032] (Uncrosslinked polymer solution preparation step) First, a vinyl alcohol polymer and a method for preparing the same will be described. The vinyl alcohol polymer is not particularly limited as long as it contains more than 50 mol% of vinyl alcohol-derived structural units relative to the total structural units constituting the vinyl alcohol polymer, and may also contain vinyl ester-derived structural units. The total amount of vinyl alcohol-derived structural units and vinyl ester-derived structural units relative to the total structural units constituting the vinyl alcohol polymer is preferably 80 mol% or more, more preferably 90 mol% or more, and even more preferably 95 mol% or more.
[0033] An example of a method for preparing a vinyl alcohol polymer is a method in which a polyvinyl ester obtained by polymerizing a vinyl ester monomer is saponified, and the ester groups in the polyvinyl ester are converted to hydroxyl groups.
[0034] Examples of the vinyl ester monomer include aliphatic vinyl esters such as vinyl formate, vinyl acetate, vinyl propionate, vinyl n-butyrate, vinyl isobutyrate, vinyl pivalate, vinyl versatate, vinyl caproate, vinyl caprylate, vinyl caprate, vinyl laurate, vinyl myristate, vinyl palmitate, vinyl stearate, and vinyl oleate; and aromatic vinyl esters such as vinyl benzoate. These may be used alone or in combination of two or more. Among the vinyl ester monomers, aliphatic vinyl esters are preferred, and vinyl acetate is more preferred from the viewpoint of preparation costs. That is, the polyvinyl ester is preferably polyvinyl acetate obtained by polymerizing vinyl acetate.
[0035] Furthermore, the polyvinyl ester may contain structural units derived from monomers other than vinyl ester-based monomers, if necessary, within the range that does not impair the effects of the present invention.Examples of such monomers include α-olefins such as ethylene, propylene, n-butene, and isobutylene; acrylic acid or its salts; alkyl acrylates such as methyl acrylate, ethyl acrylate, n-propyl acrylate, i-propyl acrylate, n-butyl acrylate, i-butyl acrylate, t-butyl acrylate, 2-ethylhexyl acrylate, dodecyl acrylate, and octadecyl acrylate; methacrylic acid or its salts; methyl methacrylate, ethyl methacrylate, n-propyl methacrylate, methyl ... Methacrylic acid alkyl esters such as i-propyl methacrylate, n-butyl methacrylate, i-butyl methacrylate, t-butyl methacrylate, 2-ethylhexyl methacrylate, dodecyl methacrylate, and octadecyl methacrylate; acrylamide, N-methylacrylamide, N-ethylacrylamide, N,N-dimethylacrylamide, diacetone acrylamide, acrylamidopropanesulfonic acid or a salt thereof, acrylamidopropyldimethylamine or a salt or quaternary salt thereof, N-methylolacrylamide, or derivatives thereof; methacrylamide derivatives such as methacrylamide, N-methylmethacrylamide, N-ethylmethacrylamide, methacrylamidepropanesulfonic acid or a salt thereof, methacrylamidepropyldimethylamine or a salt or quaternary salt thereof, N-methylolmethacrylamide or a derivative thereof; N-vinylamide derivatives such as N-vinylformamide and N-vinylacetamide; vinyl ethers such as methyl vinyl ether, ethyl vinyl ether, n-propyl vinyl ether, i-propyl vinyl ether, n-butyl vinyl ether, i-butyl vinyl ether, t-butyl vinyl ether, dodecyl vinyl ether, and stearyl vinyl ether; nitriles such as acrylonitrile and methacrylonitrile; vinyl halides such as vinyl chloride and vinyl fluoride; vinylidene halides such as vinylidene chloride and vinylidene fluoride; allyl compounds such as allyl acetate and allyl chloride; maleic acid or a salt, ester, or acid anhydride thereof; vinylsilyl compounds such as vinyltrimethoxysilane; and isopropenyl acetate. These may be used alone or in combination of two or more.
[0036] When the polyvinyl ester contains structural units derived from monomers other than vinyl ester-based monomers, the content of the structural units derived from monomers other than vinyl ester-based monomers is preferably 20 mol % or less, more preferably 10 mol % or less, and even more preferably 5 mol % or less, based on the total structural units constituting the polyvinyl ester.
[0037] The method for saponifying the polyvinyl ester is not particularly limited, and can be the same as conventional methods. For example, alcoholysis or hydrolysis using an alkali or acid catalyst can be applied. Among them, saponification reaction using methanol as a solvent and caustic soda (NaOH) as a catalyst is simple and preferable.
[0038] The viscosity-average degree of polymerization of the vinyl alcohol polymer, measured in accordance with JIS K 6726:1994, is preferably 300 or more, more preferably 450 or more, even more preferably 500 or more, and may be 1,000 or more or 1,500 or more, from the viewpoint of suppressing embrittlement when a crosslinked vinyl alcohol polymer comes into contact with a liquid and swells. Furthermore, from the viewpoint of suppressing an increase in the viscosity of an aqueous solution when preparing a crosslinked vinyl alcohol polymer and improving ease of processability, the viscosity-average degree of polymerization is preferably 10,000 or less, more preferably 5,000 or less, even more preferably 3,500 or less, and still more preferably 2,500 or less. One vinyl alcohol polymer may be used, or two or more vinyl alcohol polymers may be used in combination, each having a different viscosity-average degree of polymerization, a degree of saponification described below, and / or a 4% viscosity described below. In this case, it is preferable that at least one vinyl alcohol-based polymer has a viscosity-average degree of polymerization, a degree of saponification, and / or a 4% mass viscosity within a preferred range, and it is more preferable that all vinyl alcohol-based polymers have a viscosity-average degree of polymerization, a degree of saponification, and / or a 4% mass viscosity within a preferred range.
[0039] The degree of saponification of the vinyl alcohol polymer measured in accordance with JIS K 6726: 1994 is preferably 50 mol% or more, more preferably 60 mol% or more, and even more preferably 65 mol% or more, from the viewpoint of improving the water solubility of the vinyl alcohol polymer. The upper limit of the degree of saponification is not particularly limited, and is, for example, 100 mol%, preferably 99 mol%.
[0040] The 4% by mass viscosity of the vinyl alcohol polymer at 20°C is preferably 0.5 to 110 mPa·s, more preferably 1 to 80 mPa·s, and even more preferably 2 to 60 mPa·s. When the viscosity is within this range, the ease of preparation of the hydrogel is improved, and the mechanical strength of the hydrogel can be improved. The viscosity is measured at 20°C using a B-type viscometer (rotation speed: 12 rpm) in accordance with the rotational viscometer method of JIS K 6726:1994 for a 4% by mass aqueous solution of the vinyl alcohol polymer.
[0041] An uncrosslinked polymer solution containing the vinyl alcohol polymer can be prepared by mixing the vinyl alcohol polymer described above with a solvent. The solvent is preferably one or more solvents selected from the group consisting of water and water-soluble organic solvents. It is more preferable that the solvent contains water, and even more preferable that the solvent is water. Examples of water-soluble organic solvents include aprotic polar solvents such as dimethylformamide, dimethylacetamide, dimethyl sulfoxide, and N-methylpyrrolidone; monoalcohols such as methanol, ethanol, propanol, and isopropanol; and polyhydric alcohols such as ethylene glycol, diethylene glycol, triethylene glycol, and glycerin.
[0042] The content of the solvent in the uncrosslinked polymer solution is preferably 50% by mass or more, more preferably 55% by mass or more, even more preferably 60% by mass or more, and is preferably 99.999% by mass or less, more preferably 99.99% by mass or less, even more preferably 99.9% by mass or less, based on the total mass of the uncrosslinked polymer solution. When the uncrosslinked polymer solution contains a water-soluble organic solvent, the content thereof is preferably 30% by mass or less, more preferably 20% by mass or less, even more preferably 10% by mass or less, based on the total mass of the uncrosslinked polymer solution.
[0043] From the viewpoint of sufficient mechanical strength or dimensions of the hydrogel, the content of the vinyl alcohol-based polymer in the uncrosslinked polymer solution is preferably 0.001% by mass or more, more preferably 0.01% by mass or more, and even more preferably 0.1% by mass or more, relative to the total mass of the uncrosslinked polymer solution. Furthermore, from the viewpoint of suppressing an increase in viscosity of the uncrosslinked polymer solution and obtaining good moldability, the content of the vinyl alcohol-based polymer in the uncrosslinked polymer solution is preferably 50% by mass or less, more preferably 45% by mass or less, and even more preferably 40% by mass or less, relative to the total mass of the uncrosslinked polymer solution.
[0044] (Molding process) The method for molding the uncrosslinked polymer solution is not particularly limited, and it can be molded into shapes such as amorphous particles, spherical particles, fine molded bodies, arbitrarily shaped articles molded with a 3D printer, films, threads, hollow fibers, porous monoliths, and coated articles by known methods.
[0045] The method for forming spherical particles is not particularly limited, and known techniques can be used. Examples include suspension polymerization, membrane emulsification, microfluidics, nozzle extrusion, and spray drying. In addition to these, submerged electrospray, as described in Biotechnology and Bioengineering, 2012, Vol. 109, pp. 1561-1570, can also be used.
[0046] The suspension polymerization method is a method for obtaining spherical hydrogel particles by crosslinking an uncrosslinked polymer in a water-in-oil liquid-liquid dispersion system in which an uncrosslinked polymer solution containing a radical polymerization initiator is used as the dispersed phase and a liquid incompatible with the dispersed phase is used as the continuous phase. An emulsion stabilizer may be added to the continuous phase as needed. The dispersed phase is broken down into minute droplets by mechanical energy (typically a stirring blade), and crosslinking of the uncrosslinked polymer proceeds within the droplets.
[0047] The membrane emulsification method involves extruding an uncrosslinked polymer solution containing a radical polymerization initiator through a membrane with uniform pore size into the continuous phase to form uniform water-in-oil microdroplets, which are then crosslinked to obtain spherical hydrogel particles. As with the suspension polymerization method, an emulsion stabilizer may be added to the continuous phase as needed. Examples of membranes with uniform pore size include SPG (Shirasu Porous Glass) membranes and hydrophilic or hydrophobic membranes with uniform pores manufactured by Micropore Technologies. For example, the basic method described in Journal of Membrane Science, 2017, Vol. 524, pp. 79-86 can be used.
[0048] The microfluidic method involves flowing the continuous phase through a microchannel on the order of micrometers, injecting a dispersed phase, an uncrosslinked polymer solution containing a radical polymerization initiator, into the continuous phase through a microchannel on the order of micrometers to form microdroplets, and crosslinking the uncrosslinked polymer to obtain spherical hydrogel particles. Depending on the method of injecting the dispersed phase into the continuous phase, devices are classified into terrace-like devices, T-junctions, flow-focusing microchannel devices (FFDs), capillary devices (parallel flow, cross-flow, FFD), and the like. For example, methods such as those described in Chemical Engineering and Technology, Vol. 31, pp. 1099-1115, 2008, can be applied. Even in the microfluidic method, an emulsion stabilizer may be added to the continuous phase as needed.
[0049] Examples of the emulsion stabilizer that can be used include water-soluble polymers such as partially saponified polyvinyl alcohol, gelatin, hydroxymethyl cellulose, methyl cellulose, and carboxymethyl cellulose, and surfactants such as sodium dodecylbenzenesulfonate, sorbitan monooleate, dioctyl sulfosuccinate, polyoxyethylene sorbitan monooleate (Tween-80), and polyoxyethylene sorbitan monostearate (Tween-60).
[0050] As the liquid which is incompatible with the dispersed phase, for example, water-insoluble oil, toluene, hexane, octane (including isooctane), liquid paraffin, edible oil, and dichloroethane are commonly used.
[0051] The nozzle extrusion method involves extruding an uncrosslinked polymer solution containing a radical polymerization initiator through a nozzle into the air and dripping it onto the continuous phase, forming water-in-oil microdroplets. The uncrosslinked polymer is then crosslinked to obtain spherical hydrogel particles. To efficiently generate droplets, the uncrosslinked polymer solution can be mechanically cut, for example, by vibrating the nozzle or using a rotating disk or rotating nozzle. More specific examples of the nozzle extrusion method include those described in Chemical Papers, Vol. 62, pp. 364-374, 2008. In the nozzle extrusion method, the uncrosslinked polymer is crosslinked while the droplets are falling through the air, thereby obtaining spherical hydrogel particles without using the continuous phase.
[0052] In the nozzle extrusion method, for example, alginic acid or the like can be dissolved in an uncrosslinked polymer solution containing a radical polymerization initiator, and then the solution can be dropped into a polyvalent metal ion solution by the nozzle extrusion method to form spherical particles. This method utilizes the gelling property of alginic acid due to polyvalent metal ions, and after forming the spherical particles, the uncrosslinked polymer can be crosslinked by the method described below to obtain the hydrogel of the present invention.
[0053] In the spray drying method, an uncrosslinked polymer solution is atomized through a nozzle, a rotating disk, or the like to form fine droplets, which are then dried by heat to obtain spherical particles. Crosslinking of the uncrosslinked polymer can be carried out by irradiating the fine droplets with light when a photoradical polymerization initiator is used, or by drying the fine droplets with heat when a thermal radical polymerization initiator is used. Of course, after obtaining the dried spherical particles, the hydrogel of the present invention can be obtained by crosslinking the particles by applying light or heat depending on the type of radical polymerization initiator.
[0054] Any of these particle production methods can be suitably used to form spherical hydrogel particles. From the viewpoint of controlling the average particle size of the hydrogel, suspension polymerization using a static mixer, membrane emulsification, microfluidization, nozzle extrusion, and spray drying are preferred, with membrane emulsification, microfluidization, and nozzle extrusion being more preferred. These methods essentially have the advantage of being able to precisely define the volume of microdroplets using a fine orifice or nozzle, which contributes to controlling the average particle size. Of course, it is also a preferred method to control the average particle size of the resulting spherical particles by classifying spherical particles having a particle size distribution produced by suspension polymerization, which converts the particles into microdroplets using a stirring blade. From the viewpoint of hydrogel productivity, suspension polymerization is preferred.
[0055] A film-like hydrogel can be formed by pouring an uncrosslinked polymer solution onto a glass plate or the like sandwiched between spacers. More industrially, a film-like hydrogel can be formed by subjecting the uncrosslinked polymer solution to an extrusion molding method such as a T-die method, or a solution casting method. The solution casting method is a method in which an uncrosslinked polymer solution is poured onto a smooth casting drum or stainless steel belt and spread to form a film. A film-like hydrogel can be obtained by crosslinking the uncrosslinked polymer solution in the form of a film, or by evaporating the solvent from the uncrosslinked polymer solution in the form of a film to obtain a dried film and then crosslinking the uncrosslinked polymer.
[0056] The hydrogel filaments can be formed by the so-called wet spinning method, in which an uncrosslinked polymer solution is extruded through a nozzle into a coagulation bath such as dimethyl sulfoxide, a saturated aqueous sodium sulfate solution, or a saturated aqueous ammonium sulfate solution to form filaments, which are then crosslinked as is or after drying, thereby obtaining the hydrogel of the present invention.
[0057] Examples of methods for coating a substrate with a hydrogel to form a coated article include methods of coating a substrate with an uncrosslinked polymer solution using a roll coater such as a gravure coater, reverse coater, slot die coater, lip coater, knife coater, or comma coater; a spin coater, dip coater, spray coater, or inkjet coater. Furthermore, coating a spherical particle substrate with a hydrogel can be carried out by coating the spherical particle substrate with an uncrosslinked polymer solution using, for example, a fluidized bed granulation coater. The optimal method from the above forming methods can be freely selected depending on the shape of the desired hydrogel.
[0058] (Crosslinking Step) The crosslinking step may be performed while the molded vinyl alcohol polymer (hereinafter also referred to as molded vinyl alcohol polymer) still contains the solvent, or after the solvent has been removed from the molded vinyl alcohol polymer. If the molded vinyl alcohol polymer is crosslinked while still containing the solvent, shrinkage may be severe in the optional drying step described below, making it difficult to form the polymer into shapes such as films, threads, hollow fibers, and coatings. In this case, it is preferable to perform crosslinking after removing the solvent from the molded vinyl alcohol polymer by drying. The drying method may be the same as the method described in the drying step described below. The degree of drying may be appropriately selected depending on the composition or shape of the molded vinyl alcohol polymer or the crosslinking method. From the viewpoint of shrinkage in the optional drying step described below, the solvent content, as represented by the following formula (2), is preferably 50% by mass or less, more preferably 25% by mass or less, and even more preferably 10% by mass or less. Solvent content [%] = [(mass of solvent contained in molded vinyl alcohol-based polymer) / (mass of molded vinyl alcohol-based polymer in dry state + mass of solvent contained in molded vinyl alcohol-based polymer)] × 100 Formula (2) The solvent content can be measured using a method similar to that described in the drying process below.
[0059] The vinyl alcohol polymer may be physically crosslinked or covalently crosslinked, preferably by covalent crosslinking from the viewpoint of controlling the physical properties of the resulting hydrogel and / or enhancing the stability of the hydrogel when swollen.
[0060] Examples of methods for physically crosslinking a vinyl alcohol polymer include freezing and thawing an aqueous solution of the vinyl alcohol polymer, or dissolving the vinyl alcohol polymer in a mixed solvent of dimethyl sulfoxide and water by heating and cooling the solution to room temperature. A specific example of a method for freezing and thawing an aqueous solution of the vinyl alcohol polymer includes freezing the aqueous solution of the vinyl alcohol polymer at -20°C for 15 hours or more and then thawing it at 4°C for 8 hours or more, repeating this freeze-thaw process three or more times.
[0061] Examples of a method for crosslinking a vinyl alcohol polymer by a covalent bond include a method using a polyfunctional crosslinking agent that reacts with a side chain hydroxyl group of the vinyl alcohol polymer, and a method in which a functional group is introduced into the vinyl alcohol polymer by copolymerization or post-modification, and then the functional group is reacted.
[0062] Examples of methods using a polyfunctional crosslinking agent that reacts with the side chain hydroxyl groups of a vinyl alcohol polymer include a method of reacting a polyfunctional aldehyde compound such as glyoxal, malondialdehyde, or glutaraldehyde with a vinyl alcohol polymer under acidic conditions (polyacetal crosslinking), a method of reacting a polyfunctional epoxy compound such as epichlorohydrin or ethylene glycol diglycidyl ether with a vinyl alcohol polymer under alkaline conditions (polyether crosslinking), or a method of reacting a polyfunctional carboxylic acid compound such as maleic acid or succinic acid with a vinyl alcohol polymer (polyester crosslinking). From the viewpoint of obtaining a desirable degree of swelling and / or mechanical strength of the hydrogel, the binding amount of the polyfunctional crosslinking agent crosslinked with the vinyl alcohol polymer is preferably 0.01 to 20 mol %, more preferably 0.1 to 10 mol %, and even more preferably 0.5 to 5 mol %, based on the structural units derived from vinyl alcohol.
[0063] A method for introducing functional groups into a vinyl alcohol polymer by copolymerization and reacting the functional groups includes copolymerizing a vinyl ester monomer with a monomer other than the vinyl ester monomer that has a reactive substituent other than a hydroxyl group during the preparation of the vinyl alcohol polymer, followed by saponification to obtain a copolymerized modified polyvinyl alcohol (hereinafter sometimes abbreviated as "copolymerized modified PVA"), followed by crosslinking with a multifunctional crosslinking agent that reacts with functional groups such as carboxyl groups or amino groups present in the copolymerized modified PVA. From the viewpoint of obtaining a desired degree of swelling and / or mechanical strength of the hydrogel, the amount of the monomer having a reactive substituent other than a hydroxyl group relative to the total structural units of the vinyl alcohol polymer is preferably 0.01 to 20 mol %, more preferably 0.1 to 10 mol %, and even more preferably 0.5 to 5 mol %. In the following description, copolymer-modified PVA having a carboxy group may be referred to as "carboxylic acid-modified PVA," and copolymer-modified PVA having an amino group may be referred to as "amino-modified PVA."
[0064] Examples of monomers other than vinyl ester monomers that constitute carboxylic acid-modified PVA include α,β-unsaturated carboxylic acids such as (meth)acrylic acid, maleic acid, fumaric acid, and itaconic acid; (meth)acrylic acid alkyl esters such as methyl (meth)acrylate and ethyl (meth)acrylate; α,β-unsaturated carboxylic acid anhydrides such as maleic anhydride and itaconic anhydride, and derivatives thereof. In this specification, (meth)acrylic acid means acrylic acid or methacrylic acid. A crosslinked carboxylic acid-modified PVA can be prepared by copolymerizing a vinyl ester monomer with a monomer other than the vinyl ester monomers described above, followed by saponification to prepare a carboxylic acid-modified PVA, and then crosslinking the carboxylic acid-modified PVA with a polyfunctional crosslinking agent that reacts with the introduced carboxyl groups, such as a polyfunctional epoxy compound such as epichlorohydrin or ethylene glycol diglycidyl ether, or by crosslinking the carboxylic acid-modified PVA with a polyfunctional amino compound such as ethylenediamine, polyethyleneimine, or polyallylamine in combination with a carbodiimide condensing agent such as 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride. To obtain a desired degree of swelling and / or mechanical strength of the hydrogel, the amount of the polyfunctional crosslinking agent relative to the carboxylic acid-modified PVA is preferably 0.01 to 20 mol %, more preferably 0.1 to 10 mol %, and even more preferably 0.5 to 5 mol %, based on the total structural units of the vinyl alcohol polymer. The amount of carbodiimide condensing agent relative to the carboxy groups of the carboxylic acid-modified PVA is preferably 0.1 to 300 mol %, more preferably 1 to 200 mol %, and even more preferably 10 to 100 mol %. As will be described later, when preparing a hydrogel in which a cell adhesion factor is conjugated to a crosslinked vinyl alcohol polymer, the hydrogel can be prepared by covalently bonding (amide bond (-CONH-)) the carboxy groups introduced into the carboxylic acid-modified PVA to the amino groups of the cell adhesion factor.
[0065] Crosslinked amino-modified PVA can be prepared by copolymerizing a vinyl ester monomer with N-vinylformamide or the like, followed by saponification to prepare an amino-modified PVA, and then crosslinking the amino-modified PVA using a combination of a polyfunctional crosslinking agent (e.g., the polyfunctional epoxy compounds, polyfunctional carboxylic acid compounds such as succinic acid and maleic acid) that reacts with the introduced amino groups and the carbodiimide condensing agent. To obtain a desired degree of swelling and / or mechanical strength of the hydrogel, the amount of the polyfunctional crosslinking agent relative to the amino-modified PVA is preferably 0.01 to 20 mol %, more preferably 0.1 to 10 mol %, and even more preferably 0.2 to 5 mol %, based on the total structural units of the vinyl alcohol polymer. The amount of the carbodiimide condensing agent relative to the amino groups of the amino-modified PVA is preferably 0.1 to 300 mol %, more preferably 1 to 200 mol %, and even more preferably 10 to 100 mol %.
[0066] An example of a method for introducing functional groups into a vinyl alcohol polymer by post-modification and then reacting the functional groups is a method for introducing ethylenically unsaturated groups into the side chains of the vinyl alcohol polymer. The introduced ethylenically unsaturated groups easily react by adding an additive such as a radical initiator to induce a polymerization reaction, thereby preparing a crosslinked vinyl alcohol polymer. Furthermore, when a vinyl alcohol polymer contains ethylenically unsaturated groups, various molding methods, including 3D printing, become possible. Therefore, in a preferred embodiment, the vinyl alcohol polymer contains ethylenically unsaturated groups. The ethylenically unsaturated groups are preferably radically polymerizable groups, and specific examples include vinyl groups, (meth)acryloyl groups, (meth)acryloylamino groups; cyclic unsaturated hydrocarbon groups such as vinylphenyl groups, cyclohexenyl groups, cyclopentenyl groups, norbornenyl groups, and dicyclopentenyl groups; and derivatives thereof. The presence of ethylenically unsaturated groups in a vinyl alcohol polymer can be confirmed, for example, by nuclear magnetic resonance analysis (NMR).
[0067] The ethylenically unsaturated group is preferably introduced via a side chain or a terminal functional group of the vinyl alcohol polymer, and more preferably by reacting a hydroxyl group on the side chain of the vinyl alcohol polymer with a compound containing an ethylenically unsaturated group (hereinafter, sometimes abbreviated as "ethylenically unsaturated group-containing compound").
[0068] Examples of the ethylenically unsaturated group-containing compound to be reacted with the hydroxyl group in the side chain of the vinyl alcohol polymer include (meth)acrylic acid or its derivatives such as (meth)acrylic acid, (meth)acrylic anhydride, (meth)acrylic acid halide, (meth)acrylic acid ester, etc. These compounds are subjected to an esterification reaction or an ester exchange reaction, preferably in the presence of a base, to introduce a (meth)acryloyl group into the vinyl alcohol polymer.
[0069] Examples of the ethylenically unsaturated group-containing compound to be reacted with the hydroxyl group in the side chain of the vinyl alcohol polymer also include compounds containing an ethylenically unsaturated group and a glycidyl group in the molecule, specifically glycidyl (meth)acrylate, allyl glycidyl ether, etc. By subjecting these compounds to an etherification reaction in the presence of a base, it is possible to introduce a (meth)acryloyl group or an allyl group into the vinyl alcohol polymer.
[0070] Examples of ethylenically unsaturated group-containing compounds to be reacted with the 1,3-diol group of a vinyl alcohol polymer include compounds containing an ethylenically unsaturated group and an aldehyde group in the molecule, such as acrylaldehyde (acrolein), methacrylaldehyde (methacrolein), 5-norbornene-2-carboxaldehyde, 7-octenal, 3-vinylbenzaldehyde, and 4-vinylbenzaldehyde. By subjecting these compounds to an acetalization reaction in the presence of an acid catalyst, an ethylenically unsaturated group can be introduced into the vinyl alcohol polymer. More specifically, by subjecting, for example, 5-norbornene-2-carboxaldehyde, 3-vinylbenzaldehyde, or 4-vinylbenzaldehyde to an acetalization reaction, a norbornenyl group or a vinylphenyl group can be introduced into the vinyl alcohol polymer. Furthermore, a (meth)acryloylamino group can be introduced into a vinyl alcohol polymer by reacting with N-(2,2-dimethoxyethyl)(meth)acrylamide, etc. Methods for introducing an ethylenically unsaturated group into a vinyl alcohol polymer include reactions other than those exemplified above, and a combination of two or more reactions may be used.
[0071] Other methods for introducing the ethylenically unsaturated group include reacting a reactive substituent, such as a carboxy group present in a carboxylic acid-modified PVA or an amino group present in an amino-modified PVA, with an ethylenically unsaturated group-containing compound. The carboxy group of a carboxylic acid-modified PVA can be reacted with, for example, glycidyl methacrylate under acidic conditions to form an ester bond, thereby introducing a methacryloyl group into the carboxylic acid-modified PVA. The amino group of an amino-modified PVA can be introduced with an acryloylamino group by, for example, amidation reaction with acrylic anhydride in the presence of a base, or with a vinyloxycarbonyl group by amidation reaction with divinyl adipate. Methods for introducing an ethylenically unsaturated group via a copolymer-modified PVA include reactions other than those exemplified above, and a combination of two or more reactions may be used.
[0072] From the viewpoint of ease of preparation, the vinyl alcohol polymer having an ethylenically unsaturated group is preferably a vinyl alcohol polymer in which an ethylenically unsaturated group has been introduced via a side chain hydroxyl group or a side chain hydroxyl group such as a 1,3-diol group, and more preferably a vinyl alcohol polymer in which a side chain hydroxyl group has been subjected to an esterification reaction or transesterification reaction with (meth)acrylic acid or a derivative thereof, or a vinyl alcohol polymer in which a 1,3-diol group has been subjected to an acetalization reaction with a compound containing an ethylenically unsaturated group and an aldehyde group in the molecule.
[0073] The introduction rate of the ethylenically unsaturated group is preferably 10 mol % or less, more preferably 5 mol % or less, and even more preferably 3 mol % or less, based on the total structural units constituting the vinyl alcohol polymer, from the viewpoint of suppressing embrittlement of the hydrogel, and is preferably 0.01 mol % or more, more preferably 0.1 mol % or more, and even more preferably 0.5 mol % or more, from the viewpoint of accelerating the crosslinking reaction, rapidly forming the hydrogel, and improving the elastic modulus of the obtained hydrogel.
[0074] From the viewpoint of improving the mechanical strength of the hydrogel and introducing a functional group other than a hydroxyl group, the vinyl alcohol polymer having an ethylenically unsaturated group may further contain a structural unit derived from another monomer. Examples of the other monomer include acrylamides such as acrylamide, N-isopropylacrylamide, 2-acrylamido-2-methylpropanesulfonic acid, and N,N-dimethylacrylamide; α,β-unsaturated carboxylic acids such as (meth)acrylic acid, crotonic acid, itaconic acid, maleic acid, and fumaric acid; water-soluble radically polymerizable monomers such as vinylpyridine, hydroxyethyl(meth)acrylate, styrenesulfonic acid, and polyethylene glycol mono(meth)acrylate; and compounds having two or more ethylenically unsaturated groups in the molecule such as N,N'-methylenebisacrylamide, ethylene glycol di(meth)acrylate, diethylene glycol di(meth)acrylate, and polyethylene glycol di(meth)acrylate. From the viewpoint of improving the mechanical strength of the hydrogel, the content of the other monomer is preferably 50% by mass or less, more preferably 30% by mass or less, and even more preferably 10% by mass or less, based on the total mass of the vinyl alcohol-based polymer having an ethylenically unsaturated group.
[0075] When active energy rays or heat are applied to a vinyl alcohol polymer having an ethylenically unsaturated group, the ethylenically unsaturated group in the vinyl alcohol polymer crosslinks, thereby obtaining a crosslinked vinyl alcohol polymer. Examples of active energy rays include gamma rays, ultraviolet rays, visible light, infrared rays (heat rays), radio waves, alpha rays, beta rays, electron beams, plasma flow, ionizing rays, and particle beams. When the vinyl alcohol polymer is crosslinked by ultraviolet rays, visible light, infrared rays (heat rays), or heat among the active energy rays, it is preferable that the uncrosslinked polymer solution contains a radical polymerization initiator. Examples of radical polymerization initiators include photoradical polymerization initiators and thermal radical polymerization initiators.
[0076] The photoradical polymerization initiator is not particularly limited as long as it initiates radical polymerization by irradiation with active energy rays such as ultraviolet light or visible light. From the viewpoint of being able to wash away the photoradical polymerization initiator after crosslinking, it is preferable that the photoradical polymerization initiator be water-soluble. Specific examples of the photoradical polymerization initiator include 1-[4-(2-hydroxyethoxy)-phenyl]-2-hydroxy-2-methyl-1-propan-1-one (trade name "Omnirad 2959", manufactured by IGM RESINS B.V.), α-ketoglutaric acid, phenyl(2,4,6-trimethylbenzoyl)phosphinic acid lithium salt (trade name "L0290", manufactured by Tokyo Chemical Industry Co., Ltd.), and Eosin Y. When a photoradical polymerization initiator is used, the amount thereof is typically 0.0001 to 10 parts by mass, preferably 0.001 to 5 parts by mass, and more preferably 0.005 to 3 parts by mass, per 100 parts by mass of the vinyl alcohol-based polymer.
[0077] The thermal radical polymerization initiator is not particularly limited as long as it initiates radical polymerization by heat. Examples include azo initiators and peroxide initiators that are commonly used in radical polymerization. When a thermal radical polymerization initiator is used, the amount thereof is usually 0.001 to 30 parts by mass, preferably 0.01 to 10 parts by mass, and more preferably 0.1 to 5 parts by mass, per 100 parts by mass of the vinyl alcohol polymer.
[0078] The azo initiator is preferably water-soluble from the viewpoint of being able to be washed away after crosslinking. Specific examples thereof include 2,2'-azobis[2-(2-imidazolin-2-yl)propane]dihydrochloride (trade name "VA-044"), 2,2'-azobis[2-(2-imidazolin-2-yl)propane]disulfate dihydrate (trade name "VA-044B"), 2,2'-azobis[2-methylpropionamidine]dihydrochloride (trade name "V-50"), 2,2'-azobis[N-(2-carboxyethyl)- ... Examples of suitable azobis[2-(2-methylpropionamidine) tetrahydrate (trade name "VA-057"), 2,2'-azobis[2-(2-imidazolin-2-yl)propane] (trade name "VA-061"), 2,2'-azobis[2-methyl-N-(2-hydroxyethyl)propionamide] (trade name "VA-086"), and 4,4'-azobis(4-cyanopentanoic acid) (trade name "V-501") (all manufactured by Wako Pure Chemical Industries, Ltd.) are listed.
[0079] As the peroxide initiator, a peroxide initiator that does not generate gas is preferred from the viewpoint of improving the physical properties of the vinyl alcohol polymer, and a water-soluble peroxide initiator is preferred from the viewpoint of being able to wash away the thermal radical polymerization initiator after crosslinking. Specific examples include inorganic peroxides such as ammonium persulfate, potassium persulfate, and sodium persulfate.
[0080] Alternatively, a redox polymerization initiator, which is a combination of a peroxide initiator and a reducing agent, may be used. Known reducing agents can be used as the reducing agent. Examples of preferred reducing agents include highly water-soluble N,N,N',N'-tetramethylethylenediamine, sodium sulfite, sodium hydrogensulfite, and sodium hydrosulfite. When a redox polymerization initiator is used, the amount thereof is preferably 0.001 to 30 parts by mass, more preferably 0.01 to 10 parts by mass, and even more preferably 0.1 to 5 parts by mass, per 100 parts by mass of the vinyl alcohol polymer.
[0081] When crosslinking a vinyl alcohol polymer having a vinyl group as the ethylenically unsaturated group, for example, a polythiol having two or more thiol groups in the molecule may be added to promote crosslinking, and crosslinking may be carried out using a thiol-ene reaction. The polythiol is preferably water-soluble, and examples thereof include polythiols having a hydroxyl group such as dithiothreitol; and polythiols containing an ether bond, such as terminal thiolated products such as 3,6-dioxa-1,8-octanedithiol, polyethylene glycol dithiol, and multi-arm polyethylene glycol. When a polythiol is used, the amount thereof is preferably 0.01 to 20 mol %, more preferably 0.1 to 10 mol %, and even more preferably 0.5 to 5 mol %, based on the total structural units of the vinyl alcohol polymer.
[0082] The method for crosslinking a vinyl alcohol polymer by a covalent bond can be appropriately selected from the methods exemplified above. However, from the viewpoints of the toxicity of unreacted crosslinking agent or condensing agent contained in the hydrogel and ease of molding, a method in which a functional group is introduced into a vinyl alcohol polymer by post-modification and the functional group is reacted, in particular a method in which an ethylenically unsaturated group is introduced into a side chain of a vinyl alcohol polymer by post-modification, is preferred.
[0083] Before the molding step, the uncrosslinked polymer solution may contain, in addition to the vinyl alcohol polymer, components necessary for crosslinking, such as the crosslinking agent or initiator. When the molded vinyl alcohol polymer is dried as described above, the components necessary for crosslinking may be added after molding. As described above, optimal crosslinking conditions can be adopted depending on the vinyl alcohol polymer or crosslinking method. However, since molding after crosslinking is difficult, molding is preferably performed before crosslinking is completed. When the components necessary for crosslinking are mixed with the uncrosslinked polymer solution before the molding step, it is preferable to mix them immediately before the molding step. Furthermore, when a cell adhesion factor is included before crosslinking of the vinyl alcohol polymer and crosslinking requires heat, the temperature of the crosslinking reaction is preferably 100°C or less, more preferably 60°C or less, and even more preferably 37°C or less, from the viewpoint of maintaining the activity of the cell adhesion factor.
[0084] After the crosslinking step, the crosslinked vinyl alcohol polymer may be washed with a washing solution, if necessary. When crosslinking is performed using a water-soluble photoradical polymerization initiator or a thermal radical polymerization initiator, the photoradical polymerization initiator or the thermal radical polymerization initiator can be removed by washing. Washing can be performed by a conventional method, and may be performed once or multiple times. Examples of the washing solution include one or more selected from the group consisting of water and the water-soluble organic solvents, with water being preferred. When the washing solution is water, a buffer solution, such as a phosphate buffer, a Tris buffer, a HEPES buffer, an acetate buffer, a citrate buffer, a bicarbonate buffer, or an MES buffer, may be used in combination.
[0085] (Cell adhesion factor) In a preferred embodiment, the hydrogel contains a cell adhesion factor. In this case, the hydrogel may be a hydrogel in which the cell adhesion factor is simply encapsulated in a crosslinked vinyl alcohol polymer, or may be a complex in which the cell adhesion factor is covalently bonded to the crosslinked vinyl alcohol polymer. A complex is preferred from the viewpoint of enabling the cell adhesion factor to function stably and enabling the hydrogel to maintain the cell adhesion factor to a higher degree after the separation step described below.
[0086] The cell adhesion factor is not particularly limited as long as it is a molecule that has the property of adhering cells. Examples of such antibodies include cell adhesion proteins such as gelatin, collagen, laminin, fibronectin, vitronectin, nidogen, tenascin, thrombospondin, von Willebrand factor, osteopontin, fibrinogen, fibrin, elastin, netrin, entactin, proteoglycan, and retronectin; synthetic peptides containing cell adhesion sequences such as RGD, RGDVF, REDV, YIGSR, IKVAV, and peptides; acidic polysaccharides including glycosaminoglycans such as heparin, hyaluronic acid, chondroitin sulfate, dermatan sulfate, and heparan sulfate; polycations such as α-polylysine, ε-polylysine, α-polyarginine, and chitosan; antibodies such as anti-integrin antibodies, anti-VCAM1 antibodies, anti-E-selectin antibodies, anti-CD3 antibodies, and anti-CD28 antibodies; cell growth factors and differentiation factors, which will be described later; and cytokines, which will be described later.
[0087] The cell adhesion protein may be naturally occurring, recombinant, or a synthetic peptide chemically synthesized by solid-phase methods. When a cell adhesion protein is used as the cell adhesion factor, the molecular weight of the cell adhesion protein is not particularly limited, but preferably has a weight-average molecular weight of 5,000 to 1,000,000, and more preferably has a weight-average molecular weight of 6,000 to 800,000. When a synthetic peptide is used as the cell adhesion factor, the molecular weight of the synthetic peptide is not particularly limited, but preferably has a weight-average molecular weight of 200 to 10,000, and more preferably has a weight-average molecular weight of 250 to 7,000. When an acidic polysaccharide is used as the cell adhesion factor, the molecular weight of the acidic polysaccharide is not particularly limited, but preferably has a weight-average molecular weight of 3,000 to 2,000,000, and more preferably has a weight-average molecular weight of 4,000 to 1,200,000. When polycations are used as cell adhesion factors, the molecular weight of the polycations is not particularly limited, but preferably has a weight-average molecular weight of 2,000 to 1,000,000, and more preferably has a weight-average molecular weight of 4,000 to 500,000. When cell growth factors or differentiation factors are used as cell adhesion factors, the molecular weight of the cell growth factors or differentiation factors is not particularly limited, but preferably has a weight-average molecular weight of 3,000 to 200,000, and more preferably has a weight-average molecular weight of 5,000 to 100,000. When the hydrogel contains cell adhesion factors, the cell adhesion factors may be contained alone or in combination of two or more.
[0088] When the hydrogel contains a cell adhesion factor and the crosslinked vinyl alcohol polymer simply encapsulates the cell adhesion factor, the hydrogel containing the cell adhesion factor can be prepared by mixing the crosslinked vinyl alcohol polymer with the cell adhesion factor, or by mixing the vinyl alcohol polymer with the cell adhesion factor and then physically crosslinking or covalently crosslinking as described above. From the perspective of eliminating the possibility of a decrease or loss of activity of the cell adhesion factor due to crosslinking, it is preferable to prepare the hydrogel containing the cell adhesion factor by mixing the crosslinked vinyl alcohol polymer with the cell adhesion factor.
[0089] Hydrogels containing a cell adhesion factor, in which the cell adhesion factor is covalently bonded to a crosslinked vinyl alcohol polymer (i.e., the cell adhesion factor is complexed to the crosslinked vinyl alcohol polymer), can be prepared by activating the hydroxyl groups of the vinyl alcohol polymer and reacting them with the functional groups of the cell adhesion factor to form a covalent bond, followed by the crosslinking described above; by reacting the functional groups of a carboxylic acid-modified PVA or an amino-modified PVA with the functional groups of the cell adhesion factor to form a covalent bond, followed by the crosslinking described above; by reacting the functional groups remaining in the crosslinked carboxylic acid-modified PVA or the crosslinked amino-modified PVA with the functional groups of the cell adhesion factor to form a covalent bond; or by first introducing functional groups into hydroxyl groups, etc., contained in the crosslinked vinyl alcohol polymer for complexation, and then reacting the introduced functional groups with the functional groups of the cell adhesion factor to form a covalent bond. From the viewpoint of eliminating the possibility of a decrease or loss of activity of the cell adhesion factor due to crosslinking, it is preferable to prepare a hydrogel containing a cell adhesion factor by reacting the functional groups of the crosslinked vinyl alcohol polymer with the functional groups of the cell adhesion factor. From the viewpoint of reaction efficiency, the functional group of the cell adhesion factor is preferably an amino group, a carboxy group, or a thiol group.
[0090] Examples of methods for introducing cell adhesion factors by activating hydroxyl groups on vinyl alcohol polymers and reacting them with functional groups on the cell adhesion factors include methods using hydroxyl group activating reagents such as 1,1'-carbonyldiimidazole, di(N-succimidyl)carbonate, p-toluenesulfonyl chloride, 2,2,2-trifluoroethanesulfonyl chloride, and cyanuric chloride. Reacting these hydroxyl group activating reagents with the hydroxyl groups on the vinyl alcohol polymer enables the formation of covalent bonds between the activated hydroxyl groups and functional groups on the cell adhesion factor, such as primary or secondary amino groups, carboxy groups, and hydroxy groups. Other methods that can be used include acid anhydride reagents such as succinic anhydride, which can introduce carboxy groups to hydroxyl groups on vinyl alcohol polymers via ester bonds, and acetal reagents such as 2,2-dimethoxyethylamine, which can introduce amino groups to 1,3-diol groups on vinyl alcohol polymers via acetal bonds. The introduced carboxyl and amino groups can form amide bonds with amino or carboxyl groups of the cell adhesion factor using the carbodiimide condensing agent or the like. The introduction rate of carboxyl groups introduced via ester bonds to hydroxyl groups of the vinyl alcohol polymer is preferably 50 mol% or less, more preferably 30 mol% or less, and even more preferably 15 mol% or less, based on the total structural units constituting the vinyl alcohol polymer, from the viewpoints of maintaining the hydrogel's appropriate swelling property in solvents and maintaining physical properties such as gel strength. Furthermore, from the viewpoints of achieving an appropriate immobilization amount of the cell adhesion factor and achieving high functionality, the introduction rate is preferably 0.1 mol% or more, more preferably 0.5 mol% or more, and even more preferably 1.0 mol% or more. The amount of the hydroxyl group-activating reagent, acid anhydride reagent, or acetal reagent is typically 0.01 to 30 mol%, preferably 0.1 to 15 mol%, based on the total structural units of the vinyl alcohol polymer.
[0091] A method for introducing a cell adhesion factor into a carboxylic acid-modified PVA or an amino-modified PVA includes, for example, forming an amide bond between a carboxy group of the carboxylic acid-modified PVA or an amino group of the amino-modified PVA and an amino group or a carboxy group of the cell adhesion factor using the carbodiimide condensing agent, etc. The amount of the carbodiimide condensing agent is usually 0.1 to 300 mol %, preferably 1 to 200 mol %, relative to the carboxy group or amino group of the carboxylic acid-modified PVA or the amino-modified PVA.
[0092] Examples of methods for forming covalent bonds by reacting functional groups remaining in a crosslinked carboxylic acid-modified PVA or crosslinked amino-modified PVA with functional groups of a cell adhesion factor include methods using the above-mentioned carbodiimide condensing agent, etc. The amount of the carbodiimide condensing agent is usually 0.1 to 300 mol %, preferably 1 to 200 mol %, relative to the carboxyl or amino groups of the carboxylic acid-modified PVA or amino-modified PVA.
[0093] Examples of methods for forming covalent bonds by first introducing functional groups into hydroxyl groups or the like contained in a crosslinked vinyl alcohol polymer and then reacting the introduced functional groups with functional groups of a cell adhesion factor include methods in which the functional groups are first introduced using a hydroxyl group activating reagent, acid anhydride reagent, or acetal reagent, as described above, and then reacting the introduced functional groups with functional groups of the cell adhesion factor using a carbodiimide condensing agent or the like. The amount of the hydroxyl group activating reagent, acid anhydride reagent, or acetal reagent is typically 0.01 to 30 mol %, preferably 0.1 to 15 mol %, based on the total structural units of the crosslinked vinyl alcohol polymer. The amount of the carbodiimide condensing agent is typically 0.1 to 300 mol %, preferably 1 to 200 mol %, based on the carboxyl or amino groups of the carboxylic acid-modified PVA or amino-modified PVA. For example, when an acid anhydride reagent such as succinic anhydride is reacted with a crosslinked vinyl alcohol polymer, a carboxy group (COOH) derived from succinic acid is introduced at the end, and this carboxy group is condensed with an amino group of the cell adhesion factor using a condensing agent such as 1,1'-carbonyldiimidazole, dicyclohexylcarbodiimide, or a water-soluble carbodiimide (e.g., 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride), thereby conjugating the cell adhesion factor to the crosslinked vinyl alcohol polymer.
[0094] Alternatively, the carboxylic acid-modified PVA may be converted into an active ester using an alcohol and a carbodiimide condensing agent, and then the active ester may be condensed with the amino group of the cell adhesion factor. Examples of alcohols used for the active esterification include N-hydroxysuccinimide, N-hydroxysulfosuccinimide sodium, 1-hydroxybenzotriazole, 1-hydroxy-7-azabenzotriazole, and ethyl(hydroxyimino)cyanoacetate. However, N-hydroxysuccinimide and N-hydroxysulfosuccinimide sodium are preferred in terms of water solubility and other factors. The amount of alcohol used for the active esterification is typically 0.1 to 300 mol %, preferably 1 to 200 mol %, relative to the carboxy groups of the carboxylic acid-modified PVA.
[0095] The proportion of the crosslinked vinyl alcohol polymer in the hydrogel is, for example, 50 to 100% by mass, preferably 70 to 98% by mass, and more preferably 85 to 97% by mass, based on the total mass of the hydrogel. The masses of the hydrogel and the crosslinked vinyl alcohol polymer in this case are dry masses. When the hydrogel contains a cell adhesion factor, the proportion of the cell adhesion factor in the hydrogel is, for example, 0.00001 to 70% by mass, preferably 0.0001 to 60% by mass, and more preferably 0.0005 to 50% by mass, based on the total mass of the hydrogel. The masses of the hydrogel and the cell adhesion factor in this case are dry masses. When the hydrogel contains a cell adhesion factor, the proportion of crosslinked vinyl alcohol polymer and the proportion of cell adhesion factor in the hydrogel can be determined, for example, by determining the proportion of cell adhesion factor using the ninhydrin method, the Lowry method, the BCA method, the ELISA method, or a radiolabeling method, and then subtracting the amount of cell adhesion factor from the total amount of the hydrogel.
[0096] A preferred hydrogel is a hydrogel in which a crosslinked vinyl alcohol polymer having an ethylenically unsaturated group and a carboxy group is covalently bonded to a cell adhesion factor having an amino group. More specifically, a hydrogel in which a carboxy group of the carboxy group-containing vinyl alcohol polymer crosslinked by an ethylenically unsaturated group is amide-bonded to an amino group of the cell adhesion factor is more preferred. Formation of an amide bond allows the cell adhesion factor to be retained in the hydrogel and to function stably.
[0097] (Optional Components Other Than Cell Adhesion Factors) Examples of optional components other than cell adhesion factors that may be optionally contained in the hydrogel include polymer microparticles and inorganic microparticles. These optional components may be contained alone or in combination of two or more. When the hydrogel contains the optional component, the optional component can be mixed with a component other than the optional component to prepare a hydrogel containing the optional component. The mixing method is not particularly limited and may be selected appropriately. For example, the optional component may be mixed when mixing the crosslinked vinyl alcohol polymer with the cell adhesion factor, or the optional component may be mixed with a complex in which the cell adhesion factor is covalently bonded to the crosslinked vinyl alcohol polymer, or the optional component may be added when preparing a solution of the uncrosslinked polymer. The proportion of the optional component in the hydrogel may be selected appropriately. When the hydrogel contains one or more selected from the group consisting of polymer fine particles and inorganic fine particles, the proportion of the polymer fine particles is preferably 0.1 to 20 parts by mass, more preferably 0.5 to 20 parts by mass, and even more preferably 1 to 15 parts by mass, per 100 parts by mass of the vinyl alcohol-based polymer, from the viewpoint of improving the mechanical strength of the hydrogel. Note that the masses of the hydrogel and the optional components are those in a dry state.
[0098] (Drying Step) The hydrogel obtained after the crosslinking step contains the solvent used in the uncrosslinked polymer solution preparation step. As described above, the hydrogel before being mixed or introduced in the preparation step of the present invention may be in a dry state, or may contain a liquid such as a solvent (water, a water-soluble organic solvent) or a liquid medium, or may be in an equilibrium swollen state with the liquid.
[0099] In a preferred embodiment, the prepared hydrogel is subjected to a drying treatment to remove the solvent. The drying method is not particularly limited, and common methods such as hot air drying, ventilation drying, vacuum drying, reduced-pressure drying, and freeze drying can be used. In addition, the hydrogel can be immersed in a volatile water-soluble organic solvent to remove components such as water contained in the hydrogel, followed by drying. Examples of volatile water-soluble organic solvents include aprotic polar solvents such as dimethylformamide, dimethylacetamide, dimethyl sulfoxide, and N-methylpyrrolidone; monoalcohols such as methanol, ethanol, propanol, and isopropanol; and acetone. The drying conditions can be appropriately selected. The water content of the hydrogel after drying, as represented by the following formula (3), is preferably 75% by mass or less, more preferably 60% by mass or less, and even more preferably 40% by mass or less. Water content [%] = [(mass of water contained in the hydrogel) / (mass of the hydrogel in the dried state + mass of water contained in the hydrogel)] × 100 (Formula (3))
[0100] The appropriate method for measuring the water content of a hydrogel varies depending on the type of solvent contained in the hydrogel. When the hydrogel contains only water as a solvent, the water content of the hydrogel can be calculated by directly evaporating the water contained in the hydrogel using a heat-drying moisture meter and measuring the mass of the remaining dry hydrogel. When the hydrogel contains water and the water-soluble organic solvent, the hydrogel can be calculated by directly evaporating the water contained in the hydrogel using a heat-drying moisture meter and measuring the mass of the remaining dry hydrogel. 1 The water content can be measured by H-NMR measurement. Specifically, the hydrogel is swollen with deuterated DMSO. 1 The content of water and the water-soluble organic solvent can be calculated by determining the H-NMR spectrum and the integral value, and comparing the integral value of the peak derived from the crosslinked vinyl alcohol polymer. 1 One preferred method for measuring the water content is to confirm the presence or absence of a water-soluble organic solvent by H-NMR, and if the solution contains only water as a solvent, to then measure the water content with a heat-drying moisture meter.
[0101] (Sterilization step) The hydrogel is preferably subjected to a sterilization treatment so as to achieve the above-mentioned sterility assurance level. The sterilization treatment is usually performed after the above-mentioned drying treatment. If the hydrogel contains a cell adhesion factor, sterilization after the drying treatment is preferable because sterilization of a hydrogel in a water-containing state reduces or eliminates the activity of the cell adhesion factor.
[0102] The sterilization method is not particularly limited. Specific sterilization methods include, for example, autoclave sterilization, ethylene oxide gas sterilization, hydrogen peroxide low-temperature plasma sterilization, dry heat sterilization, chemical sterilization using glutaraldehyde or the like, and radiation sterilization using gamma rays or electron beams. Among these, when the hydrogel contains a cell adhesion factor, ethylene oxide gas sterilization, hydrogen peroxide low-temperature plasma sterilization, and radiation sterilization are preferred from the viewpoint of maintaining the activity of the cell adhesion factor, and radiation sterilization is more preferred from the viewpoint of not leaving any residue.
[0103] <Liquid medium> The liquid medium used is not particularly limited, and any liquid medium suitable for the cells can be freely selected and used. Examples of liquid media include Dulbecco's Modified Eagle's Medium (DMEM), Ham's Nutrient Mixture F12, DMEM / F12 medium, McCoy's 5A medium, Eagle's Minimum Essential Medium (EMEM), αMEM medium (alpha Modified Eagle's Minimum Essential Medium; αMEM), and MEM medium (Minimum Essential Medium; αMEM). Examples of suitable liquid media include RPM11640 medium, Iscove's Modified Dulbecco's Medium (IMDM), and the like, and a liquid medium containing one or a mixture of two or more of these can be used. Of course, other media suitable for the cells to be cultured can also be used. The liquid medium may contain fetal bovine serum, or may be xeno-free without the addition of fetal bovine serum, or a completely synthetic medium that does not contain not only fetal bovine serum but also protein components and animal components may be used.
[0104] The starting cells used are cells used as a starting material in the production method of the present invention and are capable of growing on the surface of the hydrogel of the present invention. Examples of starting cells include pluripotent stem cells, tissue stem cells, somatic cells, mammalian cell lines used for the production of useful substances such as pharmaceuticals or for treatment, and insect cells.
[0105] Pluripotent stem cells are stem cells that have the ability to differentiate into cells of any tissue (pluripotency), and examples include embryonic stem cells (ES cells), induced pluripotent stem cells (iPS cells), embryonic germ stem cells (EG cells), and germ stem cells (GS cells).
[0106] Tissue stem cells refer to stem cells that are limited to certain tissues but have the ability to differentiate into various cell types (pluripotency). Examples include bone marrow undifferentiated mesenchymal stem cells, skeletal muscle stem cells, hematopoietic stem cells, neural stem cells, liver stem cells, adipose tissue stem cells, epidermal stem cells, intestinal stem cells, spermatogonial stem cells, pancreatic stem cells (e.g., pancreatic duct epithelial stem cells), leukocyte stem cells, lymphocyte stem cells, and corneal stem cells.
[0107] Somatic cells refer to cells that make up multicellular organisms, and examples thereof include osteoblasts, chondrocytes, hematopoietic cells, epithelial cells (such as mammary epithelial cells), endothelial cells (such as vascular endothelial cells), epidermal cells, fibroblasts, mesenchymal-derived cells, cardiac muscle cells, myoblasts, smooth muscle cells, skeletal muscle cells derived from living organisms, human tumor cells, fibrocytes, EB virus mutant cells, hepatocytes, kidney cells, bone marrow cells, macrophages, hepatic parenchymal cells, small intestinal cells, mammary gland cells, salivary gland cells, thyroid cells, skin cells, plasma cells, T cells, B cells, killer cells, lymphoblasts, and pancreatic β cells.
[0108] Examples of mammalian cell lines include CRFK cells, 3T3 cells, A549 cells, AH130 cells, B95-8 cells, BHK cells, BOSC23 cells, BS-C-1 cells, C3H10T1 / 2 cells, C-6 cells, CHO cells, COS cells, CV-1 cells, F9 cells, FL cells, FL5-1 cells, FM3A cells, G-361 cells, and GP+ cells. E-86 cells, GP+envAm12 cells, H4-II-E cells, HEK293 cells, HeLa cells, HEp-2 cells, HL-60 cells, HTC cells, HUVEC cells, IMR-32 cells, IMR-90 cells, K562 cells, KB cells, L cells, L5178Y cells, L-929 cells, MA104 cells, MDBK cells, MDCK cells, MIA PaCG-2 cells, N18 cells, Namalwa cells, NG108-15 cells, NRK cells, OC10 cells, OTT6050 cells, P388 cells, PA12 cells, PA317 cells, PC-12 cells, PER. C6 cells, PG13 cells, QGH cells, Raji cells, RPMI-1788 cells, SGE1 cells, Sp2 / O-Ag14 cells, ST2 cells, THP-1 cells, U-937 cells, V79 cells, VERO cells, WI-38 cells, ψ2 cells, and ψCRE cells.
[0109] Examples of insect cells include silkworm cells (BmN cells, BoMo cells, etc.), mulberry cells, Anemone cells, Anemone cells, Spodoptera frugiperda cells (Sf9 cells, Sf21 cells, etc.), mulberry fly cells, leafroller cells, Drosophila cells, Boettcheris caudatus cells, Aedes albopictus cells, swallowtail butterfly cells, American cockroach cells, and nettle looper cells (Tn-5 cells, HIGH FIVE cells, MG1 cells, etc.).
[0110] These cells may be aggregated together or may be differentiated. The aggregated cells may have the function of an organ. The cells may be immediately collected from a living body or may be cultured. The cells collected from a living body may have formed an organ.
[0111] <Optional Components> Examples of optional components that may be contained in the composition contained in the culture vessel include serum substitutes, cell growth factors / differentiation factors, cytokines, hormones, polyanions, polyvinyl alcohol, and transferrin. These optional components can be used alone or in combination of two or more. Examples of serum substitutes include insulin, growth factors / differentiation factors, transferrin, and proteins such as albumin.
[0112] Examples of cell growth factors and differentiation factors include vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), transforming growth factor-β (TGF-β), osteonectin, angiopoietin, hepatocyte growth factor (HGF), epidermal growth factor (EGF), platelet-derived growth factor (PDGF), insulin-like growth factor (IGF), brain-derived neurotrophic factor (BDNF), ciliary neurotrophic factor (CNTF), glial cell line-derived neurotrophic factor (GDNF), Examples of such proteins include nerve growth factor (NGF), leukemia inhibitory factor (LIF), stem cell factor (SCF), bone morphogenetic protein (BMP), interferon-α, interferon-β, interferon-γ, tumor necrosis factor-α (TNF-α), tumor necrosis factor-β (TNF-β), Notch ligand (Delta-1, Delta-3, Delta-4, Jagged-1, Jagged-2, etc.
[0113] Examples of cytokines include interleukin-1α, interleukin-1β, interleukin-2, interleukin-4, interleukin-5, interleukin-6, interleukin-7, interleukin-8, interleukin-10, interleukin-11, interleukin-12, interleukin-13, interleukin-14, interleukin-15, interleukin-16, interleukin-17, interleukin-18, interferon α, interferon β, interferon γ, granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony-stimulating factor (GM-CSF), macrophage colony-stimulating factor (M-CSF), MCP-1, erythropoietin (EPO), thrombopoietin (TPO), and Flk-2 / Flt-3 ligand (FL).
[0114] Examples of hormones include melatonin, serotonin, thyroxine, triiodothyronine, epinephrine, norepinephrine, dopamine, anti-Mullerian hormone, adiponectin, adrenocorticotropic hormone, angiotensinogen, angiotensin, antidiuretic hormone, atrial natriuretic peptide, calcitonin, cholecystokinin, corticotropin-releasing hormone, follicle-stimulating hormone, gastrin, ghrelin, glucagon, gonadothrombin-releasing hormone, growth hormone-releasing hormone, human chorionic gonadotropin, human placental lactogen, growth hormone, inhibin, insulin, leptin, luteinizing hormone, melanocyte Examples of hormones that may be involved in the production of steroid hormones include steroid hormones, such as steroid hormone, steroid hormone, steroid hormone-releasing hormone, steroid hormone-stimulating hormone, steroid hormone-releasing ...
[0115] Examples of polyanions include heparin, dextran sulfate, heparan sulfate, dermatan sulfate, chondroitin sulfate, etc. These polyanions stabilize the cell growth factors and differentiation factors by binding to them, thereby promoting cell proliferation more efficiently.
[0116] Polyvinyl alcohol (PVA) can be freely selected from the vinyl alcohol polymers and modified PVA. When culturing cells, bovine serum albumin (BSA), human recombinant albumin, etc. are often added to the culture medium for the purposes of cell protection, growth factor stabilization, etc. By using PVA, a serum-free culture environment can be created in which proteins such as BSA are excluded. The content of PVA in the serum-free medium is preferably 0.01 to 0.5% by mass, more preferably 0.05 to 0.2% by mass.
[0117] <Culture Vessel> The culture vessel used in the present invention is not particularly limited, and commonly used culture vessels can be used. Examples include plates, well plates, flasks (including T-flasks, shaker flasks, spinner flasks, etc.), chamber slides, dishes, tubes, bottles, roller bottles, bags (including shaker bags), and bioreactors. Both homogeneous and heterogeneous bioreactors can be used. In homogeneous bioreactors, cells can freely contact the liquid medium and are dispersed throughout the reactor. Homogeneous bioreactors include stirred-bed, bubble-column, air-lift, and shaking bioreactors. In heterogeneous bioreactors, cells do not directly contact the liquid medium, but are stably cultured by adhering or being held on the cell culture carriers (hydrogels in the present invention). Examples of heterogeneous bioreactors include fixed-bed, fluidized-bed, stirred-bed, and hollow-fiber bioreactors. Here, a fixed-bed bioreactor is a bioreactor in which the cell culture carriers are fixed and the liquid medium flows between the cell culture carriers. Furthermore, a fluidized bed type bioreactor is one in which the cell culture carriers are not immobilized but are fluidized inside the reactor by the upward flow of the liquid medium. A stirred bed type bioreactor is one in which the cell culture carriers are fluidized by a stirring blade. The culture vessel can be freely selected depending on the purpose, from inoculation and seeding to production scale, but from the viewpoint of scale-up and adhering and growing cells on the cell culture carriers, the culture vessel is preferably a heterogeneous bioreactor. However, a homogeneous bioreactor may be used as the culture vessel of the present invention by placing cell culture carriers in it.
[0118] [Culturing step of the first production method] The conditions for the culturing step may be appropriately selected from commonly used conditions depending on the type of raw material cells or culture vessel. For example, a temperature of 37°C, humidity of 95%, CO 2 It can be cultured under conditions of a CO concentration of 5%. 2 The concentration may be 1 to 10%, or 3 to 8%.
[0119] [Detachment Step of First Production Method] In the detachment step, cultured cells are detached from the hydrogel by a liquid flow. The hydrogel of the present invention has excellent cell adhesive properties that allow it to function sufficiently as a cell culture carrier even when the culture vessel is a bioreactor, and cells grown on its surface can be easily detached by a liquid flow without using protease. Furthermore, unlike methods that recover cells cultured on cell culture carriers by dissolving the cell culture carriers, the recovered cells are not contaminated with the dissolved cell culture carriers. Furthermore, unlike methods that involve changing the temperature of a composition contained in a culture vessel for detachment, the cells can be quickly detached while maintaining their activity. Therefore, the method of the present invention allows for the stable production of cells that maintain their activity.
[0120] The reason why the hydrogel of the present invention has excellent cell adhesiveness yet allows cells grown on its surface to be easily detached by liquid flow without the use of protease is unclear, but the following reasons are thought to be the cause. However, the reasons for the present invention are not intended to be limited to the following reasons. The crosslinked vinyl alcohol polymer contained in the hydrogel has a portion that exhibits low cell adhesiveness due to hydroxy groups and a portion that exhibits high cell adhesiveness due to introduced functional groups (e.g., amino groups). Furthermore, the cell adhesion factor preferably contained in the hydrogel exhibits high cell adhesiveness. As such, the hydrogel of the present invention contains a balanced mixture of portions that exhibit high cell adhesiveness and portions that exhibit low cell adhesiveness, and therefore the hydrogel of the present invention is thought to have appropriate cell adhesiveness that allows cells to be detached by liquid flow while being sufficiently strong for culture.
[0121] From the viewpoint of maintaining cell activity, the detachment step is carried out under an environment similar to cell culture conditions, for example, a temperature of 37°C, humidity of 95%, and CO 2 However, the above temperature, humidity and / or CO 2 concentration can be adjusted for a short period of time that does not decrease the activity of the cells. 2 Concentrations above or below are acceptable. For example, CO 2 The concentration may be in the range of 1 to 10%.
[0122] From the viewpoint of cell production efficiency, the detachment step is preferably carried out after the culture step has reached a state of 60 to 100% confluence, more preferably 65 to 100% confluence, and even more preferably 70 to 100% confluence. Here, for example, 60% confluence means a state in which cells cover 60% of the surface area of the cell culture carrier. From the viewpoint of cell production efficiency, the detachment step is also preferably carried out until the cell culture carrier reaches a state of 0 to 90% confluence, more preferably 0 to 75% confluence, and even more preferably 0 to 60% confluence. The confluence rate can be measured, for example, by obtaining a microscopic image of a hydrogel sampled from inside a culture vessel and determining the area of the carrier surface covered by cells through image analysis.
[0123] In a preferred embodiment, the liquid flow is generated by one or more means selected from the group consisting of the following means (i) to (iv): (i) suction and discharge of at least a portion of the composition through a tube installed in the culture vessel, (ii) shaking of the composition, (iii) stirring of the composition with a stirring blade, and (iv) discharge of gas and / or liquid into the culture vessel.
[0124] The liquid flow in the present invention applies a high-speed liquid flow to cells present on the hydrogel surface, applying shear stress to the cells and detaching them from the hydrogel surface through the force of this stress. Therefore, any method for applying a liquid flow that can impart such shear stress is not particularly limited and can be used freely. Generally, cells can exhibit a significant decrease in activity or even die when subjected to a shear stress of 5 Pa or more. Therefore, the liquid flow in the present invention must impart a shear stress lower than this. The shear stress applied to cells varies significantly depending on the shape of the culture vessel and the conditions of the liquid flow, shaking, stirring, and dispensing. Shear stress can be determined by simulation using computational fluid dynamics (CFD) calculations.
[0125] Any tube can be used as the tube in means (i) as long as it can aspirate and discharge at least a portion of the composition. One or more tubes for aspirating at least a portion of the composition (hereinafter also referred to as aspirating tubes) may be installed depending on the amount of composition or the type of culture vessel, and the aspirating port of the aspirating tube is preferably located below the liquid level of the composition. One or more tubes for discharging at least a portion of the composition (hereinafter also referred to as discharging tubes) may also be installed depending on the amount of composition or the type of culture vessel. The aspirating tube may also function as a discharging tube, or the aspirating tube and the discharging tube may be separate tubes. When the aspirating tube and the discharging tube are separate tubes, the discharging port of the discharging tube may be located below, near, or above the liquid level of the composition. From the viewpoint of the recovery rate of detached cells, it is preferable that at least half, preferably all, of the aspirated at least a portion of the composition be returned to the culture vessel by discharging. The material of the tube, particularly the material of the inner wall of the tube, may be any material that does not adversely affect cell production. Examples of such materials include glass, stainless steel, polyethylene, polypropylene, polymethyl methacrylate, polystyrene, polycarbonate, polyester, polyethylene vinyl alcohol copolymer, polyamide, polyimide, etc., or a combination of two or more thereof. From the perspective of use in cell production, the tube is preferably sterilized, similar to the hydrogel. The cross-sectional shape of the tube is not particularly limited, and may be circular, elliptical, triangular, rectangular, star-shaped, or a combination of two or more thereof, or may have an uneven cross section. The tube may be straight, curved, or bent. The cross-sectional area of the tube may be selected appropriately depending on the amount of the composition, and may be, for example, 0.001 to 8,000 cm. 2 , preferably 0.002 to 2,000 cm 2 , more preferably 0.005 to 1,000 cm 2The flow rate may be constant or variable along the length. Components other than the hydrogel in the composition may be sucked by sucking the liquid through the suction port via a porous material, as described below. The flow rate of suction or discharge is preferably 0.0001 to 100 m / s, more preferably 0.001 to 50 m / s, and even more preferably 0.005 to 30 m / s. The number of times suction and discharge are performed is not limited. For example, one cycle of suction and discharge may be repeated multiple times, or at least a portion of the composition may be aspirated once and then discharged twice, or conversely, a portion may be aspirated twice and then discharged once. Suction and discharge may be performed continuously or intermittently.
[0126] In method (ii), the composition can be agitated using, for example, ultrasound, a vortex mixer, a rotary shaker, a seesaw (wave-type agitation) shaker, an up-and-down or left-and-right agitator, or a combination of two or more thereof. The conditions for ultrasonic treatment or vortexing may be appropriately selected depending on the amount of the composition or the type of culture vessel. Agitation can be performed continuously or intermittently. Even during agitation, the flow rate inside the culture vessel is preferably 0.0001 to 100 m / s, more preferably 0.001 to 50 m / s, and even more preferably 0.005 to 30 m / s.
[0127] In means (iii), commonly used stirring blades can be used. Examples of stirring blades include paddle blades, flat paddle blades, propeller blades, turbine blades, elephant ear blades, anchor blades, cone blades, full zone blades, ribbon blades, and screw blades. The dimensions of the stirring blades, the number of paddles or disks, and the stirring conditions can be appropriately selected depending on the amount of composition or the type of culture vessel. Stirring can be performed continuously or intermittently. Even when rocking, the flow rate inside the culture vessel is preferably 0.0001 to 100 m / s, more preferably 0.001 to 50 m / s, and even more preferably 0.005 to 30 m / s.
[0128] The gas and liquid ejected by means (iv) may be any gas and liquid that do not adversely affect the activity of the cells. Examples of gases include inert gases such as air, nitrogen, and argon, or a mixture of two or more of these. Examples of liquids include a liquid medium (preferably the same liquid medium as the liquid medium contained in the composition), physiological saline, a buffer solution, or a mixture of two or more of these. Either the gas or the liquid may be ejected, or both the gas and the liquid may be ejected. The ejection may be performed continuously or intermittently. From the viewpoint of generating a sufficient liquid flow, it is preferable that the ejection tube is thin, and when both the gas and the liquid are ejected, it is preferable that the gas ejection tube and the liquid ejection tube are separate tubes. The cross-sectional area of the tube may be selected appropriately, for example, from 0.001 to 10 cm. 2 , preferably 0.002 to 5 cm 2 , more preferably 0.005 to 1 cm 2 The flow rate may be constant or variable along the length. The tube may branch along the length. For example, when nitrogen is discharged from a tube connected to a nitrogen cylinder, the tube may have multiple outlets. The outlet of the discharge tube may be located below the liquid level of the composition, near the liquid level, or above the liquid level. Such a tube may be the same as the tube described in means (i). Discharge conditions, such as the amount of gas and liquid to be discharged, may be selected appropriately depending on the amount of composition or the type of culture vessel. For example, the discharge flow rate is preferably 0.0001 to 100 m / s, more preferably 0.001 to 50 m / s, and even more preferably 0.005 to 30 m / s.
[0129] In one embodiment of the present invention, the production method may include a step of contacting at least a portion of the composition in the culture vessel with a solution containing a protease at a concentration of preferably 1.5 mg / mL or less and a chelating agent at a concentration of preferably 0.01 mg / mL or more to detach the cultured cells from the surface of the hydrogel. This detachment step using a chelating agent may be performed before, simultaneously with, and / or after the above-mentioned liquid flow detachment step. From the viewpoint of improving cell detachability, the detachment step using a chelating agent is preferably performed before or simultaneously with the liquid flow detachment step. The number of contacts is not limited. For example, the contact may be performed once before the liquid flow detachment step and once after the liquid flow detachment step, or multiple times by replacing the solution.
[0130] The concentration of proteases (e.g., trypsin) commonly used to detach cells is usually about 2.5 mg / mL, which poses the problem of potentially damaging the cells when used to detach cells from cell culture supports. The solution used in the detachment step using a chelating agent of the present invention may contain a protease to the extent that it does not damage the cells, and the concentration is preferably 1.5 mg / mL or less, more preferably 1.0 mg / mL or less, even more preferably 0.5 mg / mL or less, and particularly preferably 0 mg / mL. The concentration of the protease in the solution can be measured, for example, by ELISA using an antigen-antibody reaction.
[0131] The chelating agent of the present invention functions to chelate calcium ions and magnesium ions, which are essential for cell-cell adhesion and adhesion between cells and cell culture carriers. The concentration of the chelating agent is preferably 0.01 mg / mL or more, more preferably 0.02 mg / mL or more, and even more preferably 0.03 mg / mL or more (e.g., 0.05 mg / mL or more, 0.08 mg / mL or more, 0.10 mg / mL or more). A chelating agent concentration above the lower limit allows for more rapid detachment of cells from the hydrogel. From the viewpoint of cell viability, the upper limit of the chelating agent concentration is typically 15 mg / mL or less, preferably 1.5 mg / mL or less. The concentration of the chelating agent in the solution can be measured, for example, by a colorimetric method using a metal complex that changes color upon chelation with copper, cobalt, or the like.
[0132] Examples of chelating agents include aminocarboxylic acid-based chelating agents such as ethylenediaminetetraacetic acid (EDTA), glycoletherdiaminetetraacetic acid (EGTA), nitrilotriacetic acid (NTA), and diethylenetriaminepentaacetic acid (DTPA); phosphate-based chelating agents such as sodium tripolyphosphate, sodium pyrophosphate, and sodium orthophosphate; and phosphonate-based chelating agents such as phosphonobutanetricarboxylic acid, aminotris(methylenephosphonic acid), 1-hydroxyethylidene-1,1-diphosphonic acid, ethylenediaminetetra(methylenephosphonic acid), and diethylenetriaminepenta(methylenephosphonic acid). These chelating agents can be used alone or in combination. From the standpoint of good cell detachment and viability, chelating agents that chelate with divalent metal ions are preferred, with chelating agents that chelate with calcium ions and magnesium ions being particularly preferred, with ethylenediaminetetraacetic acid and glycoletherdiaminetetraacetic acid being more particularly preferred, and ethylenediaminetetraacetic acid being most preferred. These may also be alkali metal salts.
[0133] Proteases are enzymes that can hydrolyze peptide bonds in proteins. Specific examples include trypsin, chymotrypsin, lysyl endopeptidase, accutase, collagenase, natural proteases, elastase, pronase, clostripain, papain, Endo Arg-C, Endo Lys-C, Endo Asn-C, etc. The solution may contain one type of protease alone or two or more types in combination.
[0134] Examples of solvents used in the peeling step using a chelating agent include physiological saline, phosphate buffered saline, Hank's balanced salt solution, Earle's balanced salt solution, N-2-hydroxyethylpiperazine-N'-ethanesulfonic acid (HEPES), and mixed solvents of two or more thereof. The solution preferably does not contain calcium ions or magnesium ions.
[0135] In this embodiment, at least a portion of the composition in the culture vessel, preferably at least 50% by mass of the composition, more preferably at least 75% by mass of the composition, and even more preferably all of the composition, is contacted with the solution. Hereinafter, "at least a portion of the composition in the culture vessel, preferably at least 50% by mass of the composition, more preferably at least 75% by mass of the composition, and even more preferably all of the composition" in this embodiment will be abbreviated as "at least a portion of the composition." "Contacting" refers to an operation in which the composition comes into contact with the solution. Specific examples of this operation include replacing a liquid component contained in at least a portion of the composition with the solution, and mixing at least a portion of the composition with the solution.
[0136] When replacing the liquid component contained in at least a portion of the composition with the solution, the amount of the replaced liquid component is preferably 20 to 100% by mass, more preferably 40 to 100% by mass, and even more preferably 60 to 100% by mass, based on the total mass of the composition. The replacement method is not particularly limited, and replacement can be performed using a known method. For example, the liquid component contained in at least a portion of the composition can be replaced with the solution by filtering at least a portion of the liquid component from the composition using a porous material that can be used in the separation step described below, and then mixing the remaining composition with the solution, or by precipitating the hydrogel in the composition in a culture vessel, removing at least a portion of the liquid component from the top of the culture vessel, and then mixing the remaining composition with the solution.
[0137] When at least a part of the composition is mixed with the solution, the amount of the solution to be mixed is preferably 1 to 1,000% by mass, more preferably 5 to 100% by mass, and even more preferably 10 to 50% by mass, based on the total mass of the composition. There are no particular limitations on the mixing method, and mixing can be performed by a known method.
[0138] The temperature when at least a portion of the composition is brought into contact with the solution is usually 0 to 40°C, preferably 15 to 37°C, from the viewpoint of cell viability and activity. The contact time can be appropriately selected depending on the concentration of the chelating agent contained in the solution, the adhesive strength of the cells, and the cell viability. The contact time is usually 1 second to 30 minutes, preferably 1 to 10 minutes, and more preferably 2 to 5 minutes.
[0139] Another method for producing cells of the present invention includes the steps of: preparing a culture vessel containing a composition comprising a liquid medium, a hydrogel comprising a crosslinked vinyl alcohol polymer, and starting cells (preparation step); culturing the starting cells on the surface of the hydrogel (culture step); and contacting at least a portion of the composition in the culture vessel with a solution containing a protease at a concentration of 1.5 mg / mL or less and a chelating agent at a concentration of 0.01 mg / mL or more to detach the cultured cells from the surface of the hydrogel (detachment step). Hereinafter, this production method will also be referred to as the "second production method." The descriptions in the "Preparation step of the first production method" and "Culturing step of the first production method" sections of the first production method can be applied to the preparation step and culture step in the second production method.
[0140] [Detachment step of the second manufacturing method] In the detachment step, at least a portion of the composition in the culture vessel is contacted with a solution containing a protease at a concentration of 1.5 mg / mL or less and a chelating agent at a concentration of 0.01 mg / mL or more to detach the cultured cells from the surface of the hydrogel. In one embodiment of the present invention, the solution is preferably a solution that does not contain a protease and contains a chelating agent at a concentration of 0.01 mg / mL or more. The number of times of contact is not limited and can be performed once or multiple times.
[0141] The concentration of proteases (e.g., trypsin) commonly used to detach cells is usually about 2.5 mg / mL, which poses the problem of potentially damaging the cells when used to detach cells from cell culture supports. The solution used in the detachment step using a chelating agent of the present invention may contain a protease to the extent that it does not damage the cells, and the concentration is 1.5 mg / mL or less, preferably 1.0 mg / mL or less, more preferably 0.5 mg / mL or less, and particularly preferably 0 mg / mL. The concentration of the protease in the solution can be measured, for example, by ELISA using an antigen-antibody reaction.
[0142] The hydrogel of the present invention has excellent cell adhesion properties that allow it to function sufficiently as a cell culture carrier even when the culture vessel is a bioreactor. However, cells grown on its surface can be easily detached using the chelating agent-containing solution described above, even when no or only low concentrations of protease are used. Furthermore, unlike methods for recovering cells cultured on cell culture carriers by dissolving the cell culture carriers, the lysed cell culture carriers are not mixed with the recovered cells. Furthermore, unlike methods that involve varying the temperature of a composition contained in a culture vessel for detachment, the cells can be quickly detached while maintaining their activity. Therefore, the method of the present invention allows for the stable production of cells with well-maintained activity.
[0143] The reason why the hydrogel of the present invention has excellent cell adhesiveness yet allows cells grown on its surface to be successfully detached using the chelating agent-containing solution even when no or only a low concentration of protease is used is unclear, but the following reasons are thought to be the cause. However, the reasons described below are not intended to limit the present invention. The crosslinked vinyl alcohol polymer contained in the hydrogel has a portion that exhibits low cell adhesiveness due to hydroxy groups and a portion that exhibits high cell adhesiveness due to the introduced functional groups (e.g., amino groups). Furthermore, the cell adhesion factor preferably contained in the hydrogel exhibits high cell adhesiveness. As such, the hydrogel of the present invention contains a well-balanced mixture of portions that exhibit high cell adhesiveness and portions that exhibit low cell adhesiveness. Therefore, the hydrogel of the present invention is thought to be strong enough for culture while also having appropriate cell adhesiveness that allows cell detachment by the action of the chelating agent-containing solution.
[0144] From the viewpoint of maintaining cell activity, the detachment step is carried out under an environment similar to cell culture conditions, for example, a temperature of 37°C, humidity of 95%, and CO 2 However, the above temperature, humidity and / or CO 2 concentration can be adjusted for a short period of time that does not decrease the activity of the cells. 2 Concentrations above or below are acceptable. For example, CO 2 The concentration may be in the range of 1 to 10%.
[0145] From the viewpoint of cell production efficiency, the detachment step is preferably carried out after the culture step has reached a state of 60 to 100% confluence, more preferably 65 to 100% confluence, and even more preferably 70 to 100% confluence. Here, for example, 60% confluence means a state in which cells cover 60% of the surface area of the cell culture carrier. From the viewpoint of cell production efficiency, the detachment step is also preferably carried out until the cell culture carrier reaches a state of 0 to 90% confluence, more preferably 0 to 75% confluence, and even more preferably 0 to 60% confluence. The confluence rate can be measured, for example, by obtaining a microscopic image of a hydrogel sampled from inside a culture vessel and determining the area of the carrier surface covered by cells through image analysis.
[0146] The chelating agent of the present invention functions to chelate calcium ions and magnesium ions, which are essential for cell-cell adhesion and adhesion between cells and cell culture carriers. The concentration of the chelating agent is 0.01 mg / mL or more, preferably 0.02 mg / mL or more, and more preferably 0.03 mg / mL or more (e.g., 0.05 mg / mL or more, 0.08 mg / mL or more, 0.10 mg / mL or more). A chelating agent concentration above the lower limit allows for more rapid detachment of cells from the hydrogel. From the viewpoint of cell viability, the upper limit of the chelating agent concentration is typically 15 mg / mL or less, preferably 1.5 mg / mL or less. The concentration of the chelating agent in the solution can be measured, for example, by a colorimetric assay using a metal complex that changes color upon chelation with copper, cobalt, or the like.
[0147] Examples of chelating agents include aminocarboxylic acid-based chelating agents such as ethylenediaminetetraacetic acid (EDTA), glycoletherdiaminetetraacetic acid (EGTA), nitrilotriacetic acid (NTA), and diethylenetriaminepentaacetic acid (DTPA); phosphate-based chelating agents such as sodium tripolyphosphate, sodium pyrophosphate, and sodium orthophosphate; and phosphonate-based chelating agents such as phosphonobutanetricarboxylic acid, aminotris(methylenephosphonic acid), 1-hydroxyethylidene-1,1-diphosphonic acid, ethylenediaminetetra(methylenephosphonic acid), and diethylenetriaminepenta(methylenephosphonic acid). These chelating agents can be used alone or in combination. From the standpoint of good cell detachment and viability, chelating agents that chelate with divalent metal ions are preferred, with chelating agents that chelate with calcium ions and magnesium ions being particularly preferred, with ethylenediaminetetraacetic acid and glycoletherdiaminetetraacetic acid being more particularly preferred, and ethylenediaminetetraacetic acid being most preferred. These may also be alkali metal salts.
[0148] Proteases are enzymes that can hydrolyze peptide bonds in proteins. Specific examples include trypsin, chymotrypsin, lysyl endopeptidase, accutase, collagenase, natural proteases, elastase, pronase, clostripain, papain, Endo Arg-C, Endo Lys-C, Endo Asn-C, etc. The solution may contain one type of protease alone or two or more types in combination.
[0149] Examples of solvents used in the peeling step using a chelating agent include physiological saline, phosphate buffered saline, Hank's balanced salt solution, Earle's balanced salt solution, N-2-hydroxyethylpiperazine-N'-ethanesulfonic acid (HEPES), and mixed solvents of two or more thereof. The solution preferably does not contain calcium ions or magnesium ions.
[0150] In this embodiment, at least a portion of the composition in the culture vessel, preferably at least 50% by mass of the composition, more preferably at least 75% by mass of the composition, and even more preferably all of the composition, is contacted with the solution. Hereinafter, "at least a portion of the composition in the culture vessel, preferably at least 50% by mass of the composition, more preferably at least 75% by mass of the composition, and even more preferably all of the composition" in this embodiment will be abbreviated as "at least a portion of the composition." "Contacting" refers to an operation in which the composition comes into contact with the solution. Specific examples of this operation include replacing a liquid component contained in at least a portion of the composition with the solution, and mixing at least a portion of the composition with the solution.
[0151] When replacing the liquid component contained in at least a portion of the composition with the solution, the amount of the replaced liquid component is preferably 20 to 100% by mass, more preferably 40 to 100% by mass, and even more preferably 60 to 100% by mass, based on the total mass of the composition. The replacement method is not particularly limited, and replacement can be performed using a known method. For example, the liquid component contained in at least a portion of the composition can be replaced with the solution by filtering at least a portion of the liquid component from the composition using a porous material that can be used in the separation step described below, and then mixing the remaining composition with the solution, or by precipitating the hydrogel in the composition in a culture vessel, removing at least a portion of the liquid component from the top of the culture vessel, and then mixing the remaining composition with the solution.
[0152] When at least a part of the composition is mixed with the solution, the amount of the solution to be mixed is preferably 1 to 1,000% by mass, more preferably 5 to 100% by mass, and even more preferably 10 to 50% by mass, based on the total mass of the composition. There are no particular limitations on the mixing method, and mixing can be performed by a known method.
[0153] The temperature when at least a portion of the composition is brought into contact with the solution is usually 0 to 40°C, preferably 15 to 37°C, from the viewpoint of cell viability and activity. The contact time can be appropriately selected depending on the concentration of the chelating agent contained in the solution, the adhesive strength of the cells, and the cell viability. The contact time is usually 1 second to 30 minutes, preferably 1 to 10 minutes, and more preferably 2 to 5 minutes.
[0154] In one embodiment of the present invention, the manufacturing method may further include a step of detaching the cultured cells from the surface of the hydrogel by a liquid flow. This detachment step by a liquid flow may be performed before the detachment step by the action of the chelating agent-containing solution, simultaneously with the detachment step by the action of the chelating agent-containing solution, and / or after the detachment step by the action of the chelating agent-containing solution. From the viewpoint of improving cell detachability, the detachment step by a liquid flow is preferably performed after the detachment step using a chelating agent or simultaneously with the detachment step using a chelating agent. The number of times the detachment step by a liquid flow is performed is not limited. For example, the detachment step by a liquid flow may be performed once before the detachment step by the action of the chelating agent-containing solution and once after the detachment step by the action of the chelating agent-containing solution, or may be performed multiple times after the detachment step using a chelating agent.
[0155] In a preferred embodiment, the liquid flow is generated by one or more means selected from the group consisting of the following means (i) to (iv): (i) suction and discharge of at least a portion of the composition through a tube installed in the culture vessel, (ii) shaking of the composition, (iii) stirring of the composition with a stirring blade, and (iv) discharge of gas and / or liquid into the culture vessel.
[0156] The liquid flow in the present invention applies a high-speed liquid flow to cells present on the hydrogel surface, applying shear stress to the cells and detaching them from the hydrogel surface through the force of this stress. Therefore, any method for applying a liquid flow that can impart such shear stress is not particularly limited and can be used freely. Generally, cells can exhibit a significant decrease in activity or even die when subjected to a shear stress of 5 Pa or more. Therefore, the liquid flow in the present invention must impart a shear stress lower than this. The shear stress applied to cells varies significantly depending on the shape of the culture vessel and the conditions of the liquid flow, shaking, stirring, and dispensing. Shear stress can be determined by simulation using computational fluid dynamics (CFD) calculations.
[0157] Any tube can be used as the tube in means (i) as long as it can aspirate and discharge at least a portion of the composition. One or more tubes for aspirating at least a portion of the composition (hereinafter also referred to as aspirating tubes) may be installed depending on the amount of composition or the type of culture vessel, and the aspirating port of the aspirating tube is preferably located below the liquid level of the composition. One or more tubes for discharging at least a portion of the composition (hereinafter also referred to as discharging tubes) may also be installed depending on the amount of composition or the type of culture vessel. The aspirating tube may also function as a discharging tube, or the aspirating tube and the discharging tube may be separate tubes. When the aspirating tube and the discharging tube are separate tubes, the discharging port of the discharging tube may be located below, near, or above the liquid level of the composition. From the viewpoint of the recovery rate of detached cells, it is preferable that at least half, preferably all, of the aspirated at least a portion of the composition be returned to the culture vessel by discharging. The material of the tube, particularly the material of the inner wall of the tube, may be any material that does not adversely affect cell production. Examples of such materials include glass, stainless steel, polyethylene, polypropylene, polymethyl methacrylate, polystyrene, polycarbonate, polyester, ethylene-vinyl alcohol copolymer, polyamide, polyimide, etc., or a combination of two or more thereof. From the perspective of use in cell production, the tube is preferably sterilized, similar to the hydrogel. The cross-sectional shape of the tube is not particularly limited, and may be circular, elliptical, triangular, rectangular, star-shaped, or a combination of two or more thereof, or may have an uneven cross section. The tube may be straight, curved, or bent. The cross-sectional area of the tube may be selected appropriately depending on the amount of the composition, and may be, for example, 0.001 to 8,000 cm. 2 , preferably 0.002 to 2,000 cm 2 , more preferably 0.005 to 1,000 cm 2The flow rate may be constant or variable along the length. Components other than the hydrogel in the composition may be sucked by sucking the liquid through the suction port via a porous material, as described below. The flow rate of suction or discharge is preferably 0.0001 to 100 m / s, more preferably 0.001 to 50 m / s, and even more preferably 0.005 to 30 m / s. The number of times suction and discharge are performed is not limited. For example, one cycle of suction and discharge may be repeated multiple times, or at least a portion of the composition may be aspirated once and then discharged twice, or conversely, a portion may be aspirated twice and then discharged once. Suction and discharge may be performed continuously or intermittently.
[0158] In method (ii), the composition can be agitated using, for example, ultrasound, a vortex mixer, a rotary shaker, a seesaw (wave-type agitation) shaker, an up-and-down or left-and-right agitator, or a combination of two or more thereof. The conditions for ultrasonic treatment or vortexing may be appropriately selected depending on the amount of the composition or the type of culture vessel. Agitation can be performed continuously or intermittently. Even during agitation, the flow rate inside the culture vessel is preferably 0.0001 to 100 m / s, more preferably 0.001 to 50 m / s, and even more preferably 0.005 to 30 m / s.
[0159] In means (iii), commonly used stirring blades can be used. Examples of stirring blades include paddle blades, flat paddle blades, propeller blades, turbine blades, elephant ear blades, anchor blades, cone blades, full zone blades, ribbon blades, and screw blades. The dimensions of the stirring blades, the number of paddles or disks, and the stirring conditions can be appropriately selected depending on the amount of composition or the type of culture vessel. Stirring can be performed continuously or intermittently. Even when rocking, the flow rate inside the culture vessel is preferably 0.0001 to 100 m / s, more preferably 0.001 to 50 m / s, and even more preferably 0.005 to 30 m / s.
[0160] The gas and liquid ejected by means (iv) may be any gas and liquid that do not adversely affect the activity of the cells. Examples of gases include inert gases such as air, nitrogen, and argon, or a mixture of two or more of these. Examples of liquids include a liquid medium (preferably the same liquid medium as the liquid medium contained in the composition), physiological saline, a buffer solution, or a mixture of two or more of these. Either the gas or the liquid may be ejected, or both the gas and the liquid may be ejected. The ejection may be performed continuously or intermittently. From the viewpoint of generating a sufficient liquid flow, it is preferable that the ejection tube is thin, and when both the gas and the liquid are ejected, it is preferable that the gas ejection tube and the liquid ejection tube are separate tubes. The cross-sectional area of the tube may be selected appropriately, for example, from 0.001 to 10 cm. 2 , preferably 0.002 to 5 cm 2 , more preferably 0.005 to 1 cm 2 The flow rate may be constant or variable along the length. The tube may branch along the length. For example, when nitrogen is discharged from a tube connected to a nitrogen cylinder, the tube may have multiple outlets. The outlet of the discharge tube may be located below the liquid level of the composition, near the liquid level, or above the liquid level. Such a tube may be the same as the tube described in means (i). Discharge conditions, such as the amount of gas and liquid to be discharged, may be selected appropriately depending on the amount of composition or the type of culture vessel. For example, the discharge flow rate is preferably 0.0001 to 100 m / s, more preferably 0.001 to 50 m / s, and even more preferably 0.005 to 30 m / s.
[0161] (Separation step) In one embodiment, the production method of the present invention (first production method and second production method) further includes a step of separating the detached cells from the hydrogel (separation step). By the separation, the produced cells and the hydrogel from which the cells have been detached can be recovered, respectively.
[0162] In a preferred embodiment, the detached cells and the hydrogel are separated using a porous material. This separation corresponds to filtration. That is, the hydrogel does not pass through the porous material, while the liquid containing the detached cells passes through the porous material. Due to the significantly larger volume of the hydrogel compared to the volume of the detached cells, the detached cells and the hydrogel can be easily and quickly separated. This easy and quick separation not only improves cell production efficiency but also better maintains the activity of the produced cells, thereby achieving more stable cell production. The porous material may be any material that can filter and separate the detached cells and the hydrogel, and examples include meshes formed by weaving threads into a network, porous sheets, punched metal, etc.
[0163] The mesh material is not particularly limited as long as it does not adversely affect cell production, and may be, for example, chemical fibers such as nylon, polyester, polypropylene, or polyethylene; metal wires such as stainless steel, aluminum, copper, brass, or titanium; or any combination thereof. The mesh shape is not particularly limited as long as it can filter and separate the detached cells and the hydrogel; for example, it may be lattice-like, polygonal, or a combination of two or more of these. The mesh opening size is not particularly limited as long as it can filter and separate the detached cells and the hydrogel; it may be selected appropriately depending on the particle size of the hydrogel. Since adherent cells typically have a diameter of 10 to 30 μm, for example, when using a hydrogel with an average particle size of 180 to 400 μm in equilibrium swollen state in phosphate-buffered saline, separation can be easily achieved by using a mesh with an opening size of 100 μm. The hydrogel of the present invention readily swells upon contact with a liquid, such as a liquid medium, and therefore exists in an equilibrium swollen state during the separation process.
[0164] The material of the porous sheet is not particularly limited as long as it does not adversely affect cell production. For example, it may be a sheet of synthetic resin such as nylon, polyester, polypropylene, or polyethylene, or a sheet of metal such as stainless steel, aluminum, copper, brass, or titanium. The thickness of the porous sheet is also not particularly limited and can be selected appropriately depending on the material and / or mechanical strength of the porous sheet. The thickness of the porous sheet is usually 0.01 mm to 5 mm, preferably 0.05 mm to 0.5 mm. The shape of the pores is not particularly limited as long as it allows for filtration separation of the detached cells and the hydrogel, and may be, for example, circular, elliptical, polygonal, slit-shaped, irregular, or a combination of two or more of these. The size of the pores is not particularly limited as long as it allows for filtration separation of the detached cells and the hydrogel, and may be selected appropriately depending on the particle size of the hydrogel. The sizes of the pores may be the same or different. For example, when using a hydrogel with an average particle size of 180 to 400 μm in an equilibrium swollen state in phosphate buffered saline, separation can be easily achieved by using a porous sheet with many circular holes with a diameter of 100 μm.
[0165] The material of the punched metal is not particularly limited as long as it does not adversely affect cell production. For example, the punched metal may be made of stainless steel, aluminum, copper, brass, titanium, etc. The thickness, shape, and size of the holes of the punched metal are not particularly limited and may be the same as those of the perforated sheet.
[0166] In another preferred embodiment, the detached cells and the hydrogel are separated based on the difference in sedimentation velocity. In this invention, the sedimentation velocity refers to the velocity at which a solid settling in a liquid becomes constant due to resistance, and is also called terminal velocity. The sedimentation velocity ν can be calculated using the following formula: ρ p : density of solid [kg / m 3 ] ρ: Liquid density [kg / m 3 ] g: Gravitational acceleration = 981 [cm / s 2 ] D p : diameter of solid [cm] Cd: resistance coefficient
[0167] For example, when the diameter of the hydrogel of the present invention is 300 μm (i.e., 0.03 cm) in an equilibrium swollen state in phosphate buffered saline, its density is approximately 1017 kg / m 3 The resistance coefficient is approximately 96.0. If the density of the liquid is 1000 kg / m 3 The sedimentation velocity of the hydrogel calculated based on the above formula is approximately 0.083 cm / s. On the other hand, the density of a cell with a diameter of 20 μm is approximately 1050 kg / m. 3 and the drag coefficient is about 15.6×10 5 The settling velocity is approximately 2.9 × 10 -4 The sedimentation velocity is calculated as cm / s. In other words, the sedimentation velocity of the hydrogel and the sedimentation velocity of the cells are significantly different. Due to this, if the culture vessel is left standing for a certain period of time after the detachment process, the hydrogel will settle to the bottom of the culture vessel, and the cells will be left floating in the culture vessel. In this state, the liquid containing the cells can be recovered by aspirating the liquid from the liquid surface in the culture vessel and separated from the hydrogel. Aspirating the liquid through the above-mentioned porous material can further reduce the contamination of the recovered liquid with the hydrogel.
[0168] Optionally, the separated hydrogel can be washed to recover cells that were attached to the hydrogel surface or present near the hydrogel. For example, the separated hydrogel can be mixed with a washing solution such as water or a buffer solution, and the above-described separation step can be repeated to recover the cells. The amount of washing solution, the mixing method, and the conditions are not particularly limited and may be selected appropriately. Furthermore, when this washing step is performed, there is no limit to the number of times it can be performed, and it may be performed once or multiple times.
[0169] The cells produced by the method of the present invention can then be recovered by subjecting the cell-containing liquid to conventional methods, such as centrifugation or the use of a cell fractionation filter.
[0170] [Reuse of Hydrogel] The hydrogel from which cells have been detached using a liquid flow and optionally a chelating agent-containing solution in the first production method, or using a chelating agent-containing solution and optionally a liquid flow in the second production method, retains its cell adhesion function and can be recovered and reused for culturing new source cells. That is, the hydrogel separated in the separation step can be reused as a cell culture carrier in cell production. Therefore, the present invention also covers a cell production method including the steps of recovering the hydrogel separated in the separation step (hydrogel recovery step), preparing a culture vessel containing a composition comprising a liquid medium, the recovered hydrogel, and source cells (re-preparation step), and culturing source cells on the surface of the recovered hydrogel (re-culture step).
[0171] The hydrogel recovered in the hydrogel recovery step can be washed with water, a buffer solution, or the like, and then used again in the preparation step. The recovered hydrogel or the washed hydrogel can also be subjected to the drying step and / or sterilization step described above.
[0172] The above-described [Preparation Step of the First Manufacturing Method] and [Culturing Step of the First Manufacturing Method] are applicable to the second preparation step and the second culture step. Following the second culture step, the same steps as the [Detachment Step of the First Manufacturing Method] or [Detachment Step of the Second Manufacturing Method] and (Separation Step) can be performed. The second detachment step may employ the same detachment step as the previous detachment step, or a different detachment step. For example, the detachment step of the first manufacturing method may be employed for both the previous and second detachment steps; the detachment step of the first manufacturing method may be employed for the previous detachment step and the detachment step of the second manufacturing method may be employed for the second detachment step; or (without departing from the spirit of the present invention) the detachment step of the second manufacturing method may be employed for the previous detachment step and the detachment step of the second detachment step may be employed (a cell detachment step different from the detachment steps of the first and second manufacturing methods). The hydrogel that has subsequently undergone the (separation step) can be further reused as a cell culture carrier.
[0173] The present invention will be described in more detail below with reference to examples, but the present invention is not limited to these examples. Physical properties in the examples and comparative examples were measured or evaluated according to the following procedures.
[0174] <Average particle size of hydrogel> A mixed solution was prepared by mixing dry hydrogel (approximately 20 mg) with phosphate buffered saline (approximately 5 mL) described below and allowing it to swell at room temperature for 2 hours. A mixed solution was prepared by mixing dry hydrogel (approximately 20 mg) with the same liquid medium (approximately 5 mL) as the liquid medium contained in the composition and allowing it to swell at room temperature for 2 hours. Each of the prepared mixed solutions was placed in a laser diffraction / scattering particle size distribution analyzer (device name: Partica LA-950, manufactured by Horiba, Ltd.), and the average particle size of the hydrogel was measured on a volume basis.
[0175] <Introduction rate of ethylenically unsaturated group and methylene succinate group> The introduction rate of ethylenically unsaturated group in the vinyl alcohol polymer having an ethylenically unsaturated group obtained in the synthesis examples described later was determined as follows: 1 The measurement was carried out by H-NMR. Specifically, the introduction rate of the ethylenically unsaturated group was determined from the ratio of the integral value of the signal of the ethylenically unsaturated group to the signal of the vinyl alcohol polymer. Similarly, the crosslinked vinyl alcohol polymer was also measured in a state where it was swollen in a heavy solvent (heavy water). 1 H-NMR measurement was carried out, and the introduction rate of methylene succinate groups was determined from the ratio of the integrated values of the signal of the methylene succinate group and the signal of the crosslinked vinyl alcohol polymer. 1 H-NMR measurement conditions Equipment: Nuclear magnetic resonance apparatus “JNM-ECX400” manufactured by JEOL Ltd. Temperature: 25°C
[0176] <Swelling degree> After leaving the dried hydrogel at room temperature under reduced pressure overnight, approximately 10 mg (W dry The swollen hydrogel was placed on a nylon mesh with a mesh size of 100 μm, and a paper sheet was placed on the nylon mesh side to absorb the phosphate buffered saline. The mass of the hydrogel (W wet ) was measured.wet / W dry The same procedure was repeated three times and the calculated value (W wet / W dry ) × 100(%) and the average value was taken as the swelling degree.
[0177] [Production Examples] [Raw Materials Used] The main components used in the Production Examples are as follows: <Raw Material PVA> PVA28-98: Polyvinyl alcohol (trade name "PVA28-98", viscosity average degree of polymerization 1700, degree of saponification approximately 98.0 to 99.0 mol%, viscosity (4 mass%, 20°C) 25.0 to 31.0 mPa s, manufactured by Kuraray Co., Ltd.) The viscosity average degree of polymerization of the raw material PVA was measured in accordance with JIS K 6726:1994. <Compounds containing ethylenically unsaturated groups> Vinyl methacrylate: manufactured by Tokyo Chemical Industry Co., Ltd. <Synthesis reagents> Triethylamine: manufactured by FUJIFILM Wako Pure Chemical Industries, Ltd. Succinic anhydride: manufactured by FUJIFILM Wako Pure Chemical Industries, Ltd. Liquid paraffin: manufactured by FUJIFILM Wako Pure Chemical Industries, Ltd. Span 80: manufactured by FUJIFILM Wako Pure Chemical Industries, Ltd. <Radical polymerization initiator> Potassium persulfate: manufactured by FUJIFILM Wako Pure Chemical Industries, Ltd. <Complexing reagents> 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride: manufactured by FUJIFILM Wako Pure Chemical Industries, Ltd. N-hydroxysuccinimide: manufactured by Tokyo Chemical Industry Co., Ltd. <Cell adhesion factors> Collagen (cell matrix, type I-C): manufactured by Nitta Gelatin Co., Ltd. <Solvents> Dimethyl sulfoxide: manufactured by FUJIFILM Wako Pure Chemical Industries, Ltd. Ion-exchanged water: Electrical conductivity 0.08 x 10 -4 Ion-exchanged water of S / m or less Phosphate buffered saline (PBS): Prepared by dissolving PBS tablets (manufactured by Takara Bio Inc.) in a specified amount of ion-exchanged water. MES buffer: Prepared by preparing a 0.1 mol / L aqueous solution of 2-morpholinoethanesulfonic acid monohydrate (manufactured by Dojindo Laboratories Ltd.), and neutralizing it with a 0.1 mol / L aqueous NaOH solution to adjust the pH to 5.6.
[0178] Synthesis Example 1 Synthesis of a vinyl alcohol polymer having an ethylenically unsaturated group 40 g (structural unit: 908 mmol) of PVA28-98 (raw material PVA) was placed in a 1 L separable flask equipped with a Dimroth condenser, 350 mL of dimethyl sulfoxide (DMSO) was added thereto, and stirring of the contents was initiated using a mechanical stirrer. The contents were heated to 80°C in a water bath and stirred at 80°C for 4 hours. After visually confirming that the raw material PVA had dissolved, 2.1 g (18.7 mmol) of vinyl methacrylate was added to the contents under stirring at 80°C, and further stirred at 80°C for 3 hours. After allowing to cool, the resulting reaction solution was poured into 2 L of stirred methanol. Stirring was stopped and the mixture was allowed to stand for 1 hour. The resulting solid was recovered and washed by immersing the recovered solid in 1 L of methanol for 1 hour. This washing process was performed a total of three times. The washed solid was vacuum-dried overnight at room temperature to obtain methacryloylated PVA (hereinafter abbreviated as "MA-PVA"). The introduction rate of ethylenically unsaturated groups (methacryloyloxy groups) in MA-PVA was 2.0 mol% based on the total structural units constituting the raw material PVA. The viscosity-average degree of polymerization of MA-PVA, measured in accordance with JIS K 6726:1994, was 1700, the same as that of the raw material PVA.
[0179] <Preparation of Dried MA-PVA Gel Spherical Particles> 440 mL of ion-exchanged water was added to 60 g of MA-PVA and stirred at 80°C for 4 hours to dissolve the MA-PVA. The resulting MA-PVA aqueous solution was cooled to room temperature, and potassium persulfate, a water-soluble thermal radical polymerization initiator, was added to this solution and dissolved to a concentration of 0.1% by mass to prepare an uncrosslinked polymer solution. 3300 mL of liquid paraffin and 8 g of Span 80 were placed in a 5 L separable flask equipped with a Dimroth condenser, and the uncrosslinked polymer solution was slowly added to the mixture. The resulting mixture was stirred at 350 rpm using a mechanical stirrer to obtain a W / O dispersion. The W / O dispersion was heated to 40°C in a water bath, and the atmosphere inside the separable flask was purged with nitrogen for 30 minutes. Stirring was then continued at 70°C for 3 hours. After cooling to room temperature, the resulting liquid paraffin containing dispersed MA-PVA gel spherical particles was filtered through a mesh with 100 μm openings. The filtered MA-PVA gel spherical particles were washed with a total of 3 L of hexane to remove the liquid paraffin, and then classified using a JIS standard sieve to obtain MA-PVA gel spherical particles with a particle size of 180 to 300 μm. These gel spherical particles were then poured into 1 L of acetone for dehydration and dried under reduced pressure to obtain dried MA-PVA gel spherical particles (hereinafter referred to as "dried MA-PVA gel spherical particles").
[0180] <Introduction of succinic acid into dried MA-PVA gel spheres> 1.5 g of dried MA-PVA gel spheres (structural units: 33 mmol) were placed in a 0.5 L separable flask equipped with a Dimroth condenser. 100 mL of dimethyl sulfoxide (DMSO) was added, and the contents were stirred using a mechanical stirrer to swell the dried MA-PVA gel spheres. The contents were stirred in a water bath at 60°C for 1 hour, after which 364 mg (3.6 mmol) of triethylamine and 330 mg (3.3 mmol) of succinic anhydride were added and stirred at 60°C for an additional 5 hours. After cooling, the gel spheres into which succinic acid had been introduced were filtered and washed twice with 100 mL of DMSO and twice with 100 mL of ion-exchanged water. The washed gel spheres were dehydrated by immersing them in 100 mL of acetone and recovering them. This dehydration process was repeated three times. The dehydrated gel spheres were dried under reduced pressure to obtain dried MA-PVA gel spheres containing succinic acid (hereinafter referred to as "dried SA-MA-PVA gel spheres"). The introduction rate of methylene succinate groups was 10.9 mol% based on the total structural units constituting MA-PVA.
[0181] <Collagen Hybridization> 1 g of dried SA-MA-PVA gel spheres (succinic acid content: approximately 1.9 mmol) was swollen overnight in MES buffer at room temperature. The swollen gel spheres were dispersed in 45 mL of MES buffer. While stirring with a magnetic stirrer, 0.78 g (6.8 mmol) of N-hydroxysuccinimide and 0.65 g (3.4 mmol) of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride were added to the dispersion and shaken at room temperature for 1 hour. The gel spheres recovered from the dispersion were washed by immersing them in 30 mL of MES buffer for 10 minutes. This washing procedure was repeated three times. The washed gel spheres were added to 70 mL of 1 mg / mL collagen MES buffer. The resulting mixture was shaken at room temperature for 3 hours, and the gel spherical particles recovered from the mixture were washed by immersing them in 70 mL of ion-exchanged water (heated to 60°C) for 20 minutes. This washing procedure was repeated twice to obtain collagen-complexed SA-MA-PVA gel spherical particles (hereinafter referred to as "collagen-SA-MA-PVA gel spherical particles"). A portion of the collagen-SA-MA-PVA gel spherical particles was immersed overnight in excess PBS, and the amount of collagen immobilized per 100 mg of gel mass was measured using the bicinchoninic acid (BCA) method (BCA Protein Assay Kit, manufactured by Takara Bio Inc.). The result was 10.5 μg / 100 mg of gel spherical particles. The remaining collagen-SA-MA-PVA gel spherical particles swollen in ion-exchanged water were dehydrated by immersing them in 50 mL of ethanol and recovering them. This dehydration process was repeated three times, and then the mixture was vacuum dried overnight at room temperature to obtain dried collagen-SA-MA-PVA gel spherical particles (hereinafter abbreviated as "hydrogel (1)").
[0182] Next, the average particle size and swelling degree of the hydrogel (1) were measured. The average particle size of the hydrogel (1) in a swollen state in phosphate-buffered saline was 350 μm, and the swelling degree was 1010%. The average particle size of the hydrogel (1) in a swollen state in DMEM medium containing 10% fetal bovine serum (hereinafter sometimes abbreviated as "serum-containing DMEM medium") was 346 μm. The surface area of the swollen hydrogel (1) per 1 g of the dry hydrogel (1), calculated from the average particle size using the following calculation method, was 1455 cm 2 <Method for calculating surface area per 1 g of hydrogel in a dry state> First, using the average particle diameter of the hydrogel swollen with phosphate buffered saline, the surface area of one hydrogel in a swollen state was calculated using the following formula (4), and the mass of one hydrogel in a dry state was calculated using the following formula (5). In this calculation, the particle size distribution was not taken into consideration, and the particles were assumed to be spherical. In addition, the density of polyvinyl alcohol was 1.19 g / cm 3 The surface area of one hydrogel in a swollen state [cm 2 / particle] = 4 × π × (average particle size of swollen hydrogel [cm] / 2) 2 Equation (4) Mass of one hydrogel in a dry state [g / piece] = [4 / 3 × π × (average particle diameter of swollen hydrogel [cm] / 2) 3 ] × (100 / swelling degree [%]) × density of polyvinyl alcohol [g / cm 3 ] Equation (5) Next, the surface area per 1 g of the hydrogel in a dry state was calculated using the following equation (6): Surface area of the swollen hydrogel per 1 g of the hydrogel in a dry state [cm 2 / g] = surface area of one hydrogel in a swollen state [cm 2 / piece] / mass of one hydrogel in dry state [g / piece] Equation (6)
[0183] <Cell Detachment by Aspirating and Discharging at Least a Part of the Composition via a Tube (Micropipette) Installed in a Culture Vessel, and Separation Using a Porous Material> [Example 1] Hydrogel (1) was dried overnight at room temperature under reduced pressure, and then 95 mg of the hydrogel was weighed out. The surface area per 1 g of the dried hydrogel (1) was 1455 cm 2 / g, the total surface area of the weighed hydrogel (1) is 138 cm 2 Next, 30 mL of serum-containing DMEM medium was added to a sterilized Erlenmeyer flask (volume 125 mL, manufactured by Thermo Fisher Scientific) as a culture vessel, and the weighed hydrogel (1) was added and allowed to stand for 30 minutes to swell. 8.10 × 10 5 Cultured mouse fibroblast NIH / 3T3 cells (obtained from the cell bank ECACC) were added as starting cells. 2The Erlenmeyer flask was placed in a shaker (Yamato Scientific Co., Ltd.) installed in an incubator at 37°C and cultured at a rotation speed of 85 rpm for 4 days. The resulting composition containing cells, hydrogel, and 30 mL of medium was transferred to a 50 mL centrifuge tube, and approximately 4.5 mL of the composition was aspirated and dispensed using a 5 mL micropipette (1 mm diameter at the tip of the aspirating and dispensing port) to generate a liquid flow, detaching the cultured cells from the hydrogel surface. One aspirating and one dispensing cycle were performed within approximately 1 second, with 50 cycles of one aspirating and one dispensing cycle. During aspirating and dispensing, the micropipette was positioned so that the aspirating and dispensing port was always below the liquid surface of the composition. The resulting cell suspension was then passed through a cell strainer (Falcon) with a 100 μm mesh to separate the hydrogel from the cell suspension. The number of cells contained in the filtrate (cell suspension) was counted using a hemocytometer, and this was designated as the "number of cells detached by pipetting." Next, to recover the cells still present on the surface of the hydrogel on the cell strainer, cell detachment was performed using a conventional cell recovery method, trypsin (concentration 2.5 mg / mL)-EDTA (concentration 0.29 mg / mL). Specifically, the hydrogel on the cell strainer was immersed in 5 mL of trypsin-EDTA solution and incubated at 5% CO 2The cells were then placed in a 37°C incubator for 3 minutes. 5 mL of serum-containing DMEM medium was then added to inactivate the trypsin. The hydrogel and cell suspension were then separated using a cell strainer, as described above. The number of cells in the resulting filtrate (cell suspension) was counted and recorded as the "number of cells remaining after trypsin detachment." Subsequent microscopic observation revealed no cells remaining on the surface of the hydrogel after cell detachment with trypsin-EDTA. The cell recovery rate was calculated using the following formula (7): Cell recovery rate [%] = (number of cells detached by pipetting) / [(number of cells detached by pipetting + number of cells remaining after trypsin detachment)] × 100. The same procedure was repeated three times to determine the number of cells detached by pipetting, the number of cells remaining after trypsin detachment, and the cell recovery rate. The average values were calculated and used as the number of cells detached by pipetting, the number of cells remaining after trypsin detachment, and the cell recovery rate for hydrogel (1). These average values are shown in Table 1.
[0184] [Comparative Example 1] Instead of hydrogel (1), a commercially available cell culture carrier, Cytodex TM NIH / 3T3 cells were cultured in the same manner as in the preparation and culture steps of Example 1, except that Cytodex 3 (manufactured by Cytiva, main component: cross-linked dextran) was used. TM The surface area of 3 is 2000 cm according to the catalog value. 2 / g and the total area is 138 cm 2 The cells were added to the culture vessel so that the amount of the cell culture medium was 1000 mg / L. The same method as in Example 1 was used except that the composition containing the cells, cell culture carriers, and medium obtained above was used. TM The number of cells detached by pipetting, the number of cells remaining after trypsin detachment, and the cell recovery rate were determined. The results are shown in Table 1.
[0185] [Comparative Example 2] Instead of hydrogel (1), a commercially available cell culture carrier, Corning (登録商標) NIH / 3T3 cells were cultured in the same manner as in the preparation and culture steps of Example 1, except that CellBIND surface microcarriers (manufactured by Corning, main component: polystyrene) were used. (登録商標)The surface area of the CellBIND surface microcarrier is 360 cm according to the catalog value. 2 / g and the total area is 138 cm 2 The same method as in Example 1 was used except that the composition containing the cells, cell culture carriers, and medium obtained above was used. (登録商標) The number of cells detached by pipetting, the number of cells remaining after trypsin detachment, and the cell recovery rate were determined for the CellBIND surface microcarriers. The results are shown in Table 1.
[0186]
[0187] As is clear from the results of Example 1 and Comparative Examples 1 and 2, when a hydrogel containing a crosslinked vinyl alcohol polymer was used, the recovery rate of cells detached by pipetting was higher than when other commercially available cell culture carriers were used, with 50% or more of the cells being recovered. Thus, according to the present invention, cells can be detached from cell culture carriers by liquid flow, and cells whose activity is well maintained can be stably produced.
[0188] <Cell Detachment by Agitation of Composition, Separation Using Porous Material> [Example 2] A cultured Erlenmeyer flask obtained in the same manner as in Example 1, using the same preparation and culture steps, was placed in a shaker and rocked at 125 rpm for 10 minutes. The resulting cell suspension was separated into hydrogel and cell suspension using a cell strainer in the same manner as in Example 1, and the number of cells contained in the resulting filtrate (cell suspension) was counted, which was designated the "cell count detached by agitation." Another hydrogel containing cells on its surface was filtered using a cell strainer from a cultured Erlenmeyer flask obtained in the same manner as in Example 1, using the same preparation and culture steps. The filtered hydrogel containing cells on its surface was subjected to cell detachment using trypsin-EDTA in the same manner as in Example 1, and the cell count was designated the "cell count detached by trypsin." Subsequent microscopic observation revealed no cells present on the surface of the hydrogel after cell detachment using trypsin-EDTA. The cell recovery rate was calculated using the following formula (8): Cell recovery rate [%] = [(number of cells detached by shaking) / (number of cells detached by trypsin)] × 100 Equation (8) The same procedure was repeated three times to determine the number of cells detached by shaking, the number of cells detached by trypsin, and the cell recovery rate. The average values were calculated and used as the number of cells detached by shaking, the number of cells detached by trypsin, and the cell recovery rate for hydrogel (1). The average values are shown in Table 2.
[0189] [Comparative Examples 3 and 4] Cytodex was cultured in the same manner as in Example 2, except that the compositions containing cells, cell culture carriers, and media obtained in the preparation step and culture step of Comparative Example 1 and the preparation step and culture step of Comparative Example 2, respectively, were used. TM 3 (Comparative Example 3) and Corning (登録商標) The number of cells detached by shaking, the number of cells detached by trypsin, and the cell recovery rate were determined for each of the CellBIND surface microcarriers (Comparative Example 4). The results are shown in Table 2.
[0190]
[0191] <Cell Detachment by Agitation of the Composition, Separation Utilizing Differences in Sedimentation Rates> [Example 3] After culturing using the same preparation and culturing steps as in Example 1, Erlenmeyer flasks were placed in a shaker and rocked at 125 rpm for 10 minutes. The resulting cell suspension was transferred to a 50 mL centrifuge tube, and 25 mL of serum-containing DMEM medium was added. The centrifuge tube was then rotated and stirred. The hydrogel was then allowed to settle by standing the centrifuge tube upright for 1 minute, and approximately 20 mL of cell suspension was recovered from the liquid surface of the centrifuge tube. The number of cells contained in the recovered cell suspension was counted as in Example 1. The same procedure was repeated three times to determine the number of cells detached by agitation. The average value was calculated and used as the number of cells detached by agitation for hydrogel (1). The average value is shown in Table 3.
[0192]
[0193] <Reuse of Hydrogel from Which Cells Have Been Detached by Vibration of Composition as a Cell Culture Carrier> [Example 4] The hydrogel precipitated in Example 3 was observed under a microscope, and it was confirmed that the cells had been completely detached. This hydrogel was washed twice with 40 mL of PBS and then reused as a cell culture carrier, and cell culture was carried out in the same manner as in Example 1. After the culture, the hydrogel was subjected to cell detachment using trypsin-EDTA in the same manner as in Example 2, whereby the cells were detached from the hydrogel, and the number of recovered cells was counted, which was 3.80 × 10 6 Since the number of cells obtained was equivalent to that obtained by the culture using the novel hydrogel in Example 2, it was confirmed that the hydrogel recovered by the production method of the present invention can be reused as a cell culture carrier.
[0194] [Example 5] (Number of trypsin-detached cells) After drying the hydrogel (1) overnight at room temperature under reduced pressure, 95 mg of the hydrogel (1) was weighed out. The surface area per 1 g of the dried hydrogel (1) was 1455 cm 2 / g, the total surface area of the weighed hydrogel (1) is 138 cm 2Next, 30 mL of serum-containing DMEM medium was added to a sterilized Erlenmeyer flask (volume 125 mL, manufactured by Thermo Fisher Scientific) as a culture vessel, and the weighed hydrogel (1) was added and allowed to stand for 30 minutes to swell. 8.10 × 10 5 Cultured mouse fibroblast NIH / 3T3 cells (obtained from the cell bank ECACC) were added as starting cells. 2 The Erlenmeyer flask was placed on a shaker (Yamato Scientific Co., Ltd.) installed in an incubator at 37°C and cultured for 4 days at a rotation speed of 85 rpm. The resulting composition containing cells, hydrogel, and 30 mL of medium was filtered using a cell strainer (Falcon) with a 100 μm mesh. The filtered hydrogel was subjected to cell detachment using a conventional cell recovery method: trypsin (concentration 2.5 mg / mL)-EDTA (concentration 0.29 mg / mL). Specifically, the filtered hydrogel was immersed in 5 mL of trypsin-EDTA solution and incubated in 5% CO. 2 The mixture was allowed to stand in an incubator at 37°C for 3 minutes, and then 5 mL of serum-containing DMEM medium was added to inactivate the trypsin.Then, as in the above procedure, the hydrogel and the cell suspension were separated by filtration using a cell strainer, and the number of cells contained in the resulting filtrate (cell suspension) was counted and defined as the "number of trypsin-detached cells."
[0195] (Number of detached cells when a trypsin-EDTA solution was used) Cells and hydrogel were similarly filtered from a cultured composition obtained in the same manner as in the preparation and culture steps described above. Cells were detached from the filtered hydrogel using a trypsin-EDTA solution with the same EDTA concentration but a different trypsin concentration from the trypsin-EDTA solution used in the above (Number of detached cells with trypsin). Specifically, the filtered hydrogel was immersed in 5 mL of trypsin-EDTA solution and incubated in 5% CO 2The mixture was left in a 37°C incubator for 3 minutes, and then 5 mL of serum-containing DMEM medium was added to inactivate the trypsin. The hydrogel and cell suspension were then separated using a cell strainer, as described above. The number of cells in the resulting filtrate (cell suspension) was counted, and this was designated the "number of detached cells using trypsin-EDTA solution." The trypsin concentration was adjusted by diluting a trypsin (concentration 2.5 mg / mL)-EDTA (concentration 0.29 mg / mL) solution with a separately prepared PBS solution of EDTA (concentration 0.29 mg / mL). Cell detachment was also performed in the same manner as described above, using a PBS solution of EDTA (concentration 0.29 mg / mL) without trypsin as a solution with a trypsin concentration of 0 mg / mL, and the number of detached cells using this solution was determined.
[0196] (Cell Recovery Rate) The percentage (cell recovery rate) of the number of detached cells when using each trypsin-EDTA solution with different trypsin concentrations relative to the number of trypsin-detached cells was calculated using the following formula (9): Cell recovery rate [%] = [(number of detached cells when using each trypsin-EDTA solution) / (number of trypsin-detached cells)] × 100 Formula (9) The same procedure was repeated three times to determine the number of detached cells, the number of trypsin-detached cells, and the cell recovery rate when using each trypsin-EDTA solution. The average values were calculated and used as the number of detached cells, the number of trypsin-detached cells, and the cell recovery rate for hydrogel (1) when using each trypsin-EDTA solution. The average cell recovery rates are shown in Table 4.
[0197] [Comparative Example 5] Instead of hydrogel (1), a commercially available cell culture carrier, Cytodex TM NIH / 3T3 cells were cultured in the same manner as in Example 5, except that Cytodex 3 (manufactured by Cytiva, main component: cross-linked dextran) was used. TM The surface area of 3 is 2000 cm according to the catalog value. 2 / g and the total area is 138 cm 2 The cells were added to the culture vessel so that the amount of the cell culture medium was 1000 mg / L. The same method as in Example 5 was used except that the composition containing the cells, cell culture carriers, and medium obtained above was used.TM The cell recovery rate was determined when each of the three trypsin-EDTA solutions was used. The results are shown in Table 4.
[0198] [Comparative Example 6] Instead of hydrogel (1), a commercially available cell culture carrier, Corning (登録商標) NIH / 3T3 cells were cultured in the same manner as in the preparation and culture steps of Example 5, except that CellBIND surface microcarriers (manufactured by Corning, main component: polystyrene) were used. (登録商標) The surface area of the CellBIND surface microcarrier is 360 cm according to the catalog value. 2 / g and the total area is 138 cm 2 The same method as in Example 5 was used except that the composition containing the cells, cell culture carriers, and medium obtained above was used. (登録商標) The cell recovery rate was determined when each trypsin-EDTA solution was used on the CellBIND surface microcarrier, and the results are shown in Table 4.
[0199]
[0200] As is clear from the results of Example 5 and Comparative Examples 5 and 6, when a hydrogel containing a crosslinked vinyl alcohol polymer is used, the cell recovery rate is substantially higher without the use of protease than when other commercially available cell culture carriers are used. Thus, according to the present invention, cells can be detached from cell culture carriers using a chelating agent-containing solution with a protease concentration of 1.5 mg / mL or less, and cells with well-maintained activity can be stably produced.
[0201] Example 6 (Number of Trypsin-Detached Cells) Cells and hydrogel were filtered from a cultured composition obtained in the same manner as in the preparation and culture steps of Example 5 using a cell strainer (manufactured by Falcon) equipped with a 100 μm mesh. The filtered hydrogel was subjected to cell detachment using trypsin (concentration 2.5 mg / mL)-EDTA (concentration 0.29 mg / mL), a conventional cell recovery method, in the same manner as in Example 5, and the number of detached cells was counted and designated as the "number of trypsin-detached cells." The number of trypsin-detached cells was 3.72 × 10 6 There were 100 pieces.
[0202] (Number of detached cells when using EDTA PBS solution) Cells and hydrogel were similarly filtered from the cultured composition obtained in the same manner as in the preparation and culture steps described above. Cell detachment was similarly performed on the filtered hydrogel using a trypsin-free EDTA PBS solution (EDTA concentration 0.29 mg / mL) as a solution with a trypsin concentration of 0 mg / mL, and the "number of detached cells when using EDTA PBS solution" was calculated using this solution. Cell detachment was similarly performed using separately prepared trypsin-free EDTA PBS solutions (EDTA concentrations 0.15 mg / mL, 0.07 mg / mL, or 0.04 mg / mL), and the "number of detached cells when using EDTA PBS solution" was calculated using each solution.
[0203] (Cell Recovery Rate) The percentage of the number of detached cells (cell recovery rate) when using PBS solutions of each EDTA with different EDTA concentrations relative to the number of trypsin-detached cells was calculated using the following formula (10): Cell Recovery Rate [%] = [(Number of detached cells when using PBS solutions of each EDTA) / (Number of trypsin-detached cells)] × 100 Formula (10) The same procedure was repeated three times to determine the number of detached cells, number of trypsin-detached cells, and cell recovery rate when using PBS solutions of each EDTA. The average values were calculated and used as the number of detached cells, number of trypsin-detached cells, and cell recovery rate for hydrogel (1) when using PBS solutions of each EDTA. The average cell recovery rate is shown in Table 5.
[0204] [Comparative Examples 7 and 8] Cytodex was cultured in the same manner as in Example 6, except that compositions containing cells, cell culture carriers, and media obtained in the same manner as in the preparation and culture steps of Comparative Example 5 and Comparative Example 6 were used. TM 3 (Comparative Example 7) and Corning (登録商標) For each of the CellBIND surface microcarriers (Comparative Example 8), the cell recovery rate was determined when each EDTA solution in PBS was used. The results are shown in Table 5.
[0205]
[0206] As is clear from the results of Example 6 and Comparative Examples 7 and 8, the use of a hydrogel containing a crosslinked vinyl alcohol polymer resulted in a higher cell recovery rate than the use of other commercially available cell culture carriers. Thus, according to the present invention, even when a chelating agent-containing solution that does not contain protease is used, cells can be detached from cell culture carriers, and cells with their activity well maintained can be stably produced.
[0207] Example 7: Cell detachment was performed in the same manner as in Example 6, except that the chelating agent in the trypsin-free EDTA PBS solution was changed from EDTA (concentration 0.29 mg / mL) to EGTA (concentration 0.38 mg / mL) and the incubation time was changed from 3 minutes to 5 minutes. As a result, the cell recovery rate obtained was 89.0%. This result confirmed that a similar cell detachment effect could be obtained even when the chelating agent was changed from EDTA to EGTA.
[0208] Example 8 The hydrogel from which cells had been detached using a PBS solution of EDTA (0.29 mg / mL) in Example 6 was observed under a microscope, and it was confirmed that the cells had been completely detached. This hydrogel was washed twice with 40 mL of PBS and then reused as a cell culture carrier, and cell culture was carried out in the same manner as in the culture step of Example 5. After culture, the hydrogel was subjected to cell detachment using trypsin (concentration 2.5 mg / mL)-EDTA (concentration 0.29 mg / mL) in the same manner as in Example 6 when measuring the number of trypsin-detached cells. The number of recovered cells was measured and found to be 3.80 × 10 6 The number of cells obtained was equivalent to that obtained by culturing using the novel hydrogel in Example 6, confirming that the hydrogel recovered by the production method of the present invention can be reused as a cell culture carrier.
Claims
1. A method for producing cells, comprising the steps of: preparing a culture vessel containing a composition comprising a liquid medium, a hydrogel comprising a crosslinked vinyl alcohol polymer, and raw material cells; culturing the raw material cells on the surface of the hydrogel; and detaching the cultured cells from the surface of the hydrogel by a liquid flow.
2. A method for producing cells, comprising the steps of: preparing a culture vessel containing a composition comprising a liquid medium, a hydrogel comprising a crosslinked vinyl alcohol polymer, and raw material cells; culturing the raw material cells on the surface of the hydrogel; and contacting at least a portion of the composition in the culture vessel with a solution having a protease concentration of 1.5 mg / mL or less and a chelating agent concentration of 0.01 mg / mL or more, to detach the cultured cells from the surface of the hydrogel.
3. The method according to claim 2, further comprising the step of detaching the cultured cells from the surface of the hydrogel by a liquid flow.
4. The method according to claim 1 or 3, wherein the liquid flow is generated by one or more means selected from the group consisting of the following means (i) to (iv): (i) suction and discharge of at least a portion of the composition through a tube installed in the culture vessel, (ii) rocking of the composition, (iii) stirring of the composition with a stirring blade, and (iv) discharge of gas and / or liquid into the culture vessel.
5. The method of claim 1 or 2, wherein the hydrogel comprises a cell adhesion factor.
6. The method according to claim 1 or 2, wherein the hydrogel is in the form of irregular particles, spherical particles, micromolded bodies, arbitrarily shaped articles formed by a 3D printer, films, threads, hollow fibers, porous monoliths, coated articles, or a mixture of two or more thereof.
7. The method according to claim 6, wherein the hydrogel in an equilibrium swollen state in a liquid medium is in the form of spherical particles having an average particle size of 10 to 5,000 μm.
8. The method according to claim 1 or 2, wherein the vinyl alcohol polymer has an ethylenically unsaturated group and a viscosity average degree of polymerization measured in accordance with JIS K 6726:1994 of 300 or more.
9. The method of claim 2, wherein the chelating agent is ethylenediaminetetraacetic acid or glycoletherdiaminetetraacetic acid.
10. The method of claim 1 or 2, wherein the culture vessel is a bioreactor.
11. The method of claim 1 or 2, further comprising the step of separating the detached cells from the hydrogel.
12. The method according to claim 11, wherein the detached cells and the hydrogel are separated using a porous material.
13. The method of claim 11, wherein the detached cells and the hydrogel are separated by difference in sedimentation velocity.
14. A method for producing cells, comprising: recovering the hydrogel separated by the method according to claim 11; preparing a culture vessel containing a composition comprising a liquid medium, the recovered hydrogel, and starting cells; and culturing the starting cells on the surface of the recovered hydrogel.
Citation Information
Patent Citations
Temperature-sensitive polymeric compound, its production, temperature-sensitive polymer composition, and cell culture substrate
JP1999349643A
Methods for culturing stem cells
JP2018201403A
Soluble microcarriers for culturing cells and related methods
JP2022536651A
Control window camera direction to avoid saturation from strong background light and actively adjust frame time on spinning camera to achieve directional control
JP2023080024A
Method for supporting transaction of unlisted stocks and unlisted stock transaction server using the same
JP2023080030A
